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Abstract 
The SKIN functions as a protective physical barrier against the outside 1 and has a primary 
role to protect body from external influences such as pathogenic microorganisms and 
mechanical injuries 2. Moreover in the skin, the interaction of keratinocytes, fibroblasts and 
melanocytes is tightly controlled by various factors and cascades 3. Under normal conditions, 
there is a balance between cell types via cell–cell contact and the extracellular matrix (ECM). 
The ECM provides structural scaffolding for cells, as well as contextual information 4,56. The 
disruption of these equilibria can result in an uncontrolled stroma degeneration (as involved in 
scarring) 7 or uncontrolled proliferation of epithelial cells (as in malignant melanoma) 8.  
Wound healing is a highly organized series of processes resulting in tissue integrity and 
function of the damaged tissue; this process needs a complex microenvironement to be 
studied. Carcinogenesis is defined as complex, adaptive process, controlled by intricate 
communications between the host and the tissue microenvironment 6. Thus, the 
microenvironment and the stroma play an important role in both wound healing process and 
tumour development.  
In this perspective, in the present PhD thesis a tissue engineering bottom-up approach was 
used to fabricate a 3D dermis tissue. This model was composed by a cell-synthesized and 
responsive extracellular matrix that resembles the in vivo dermis, and it was used as living 
platform to study in vitro skin alteration and diseases. 
The first model of skin alteration dealt with the wound healing process, by exploiting its self-
repairing capability. Interestingly, the relationship between cell migration, differentiation 
marker and ECM production and remodeling during repair process followed the same in vivo 
timing. Moreover, the presence of a responsive dermis allowed possibility to evaluate 
granulation tissue and to study and understand processes involved in scarring. Indeed, due to 
the endogenous nature of the stroma, the model proposed could represent a valuable tool to 
in vitro study tissue status at both cellular and extracellular level after a physical damage.  
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At least, once demonstrated dermis responsivity, we investigated epidermal counterpart. In 
this perspective, we fabricated a 3D human skin equivalent (3D-HSE) model with the same 
endogenous stroma as dermis component to study cell-ECM – with native basement 
membrane (BM) – and cell–cell communications, in the presence of an aggressive form of 
skin cancer: melanoma. As a fact, carcinogenesis can disrupt these forms of communication , 
thus altering cell biology of human skin 6,9 
Consequently, we investigated the role of skin cells and BM components on melanoma 
biology and invasive ability in reconstructed human skin equivalent. We first made-up and 
characterized a human skin model that resembled the architecture of skin in situ, than we 
carried out an analogous procedure for the equivalent engineered tumor model. On the basis 
of our results, we can assert that there is communication between skin cells and melanoma 
cells and the outcome is dictated by the nature of the melanoma cells. Thus, the 
bioengineered 3D melanoma skin model may become a valuable tool to investigate the 
underlying mechanics of melanoma infiltration. The proposed study does not recapitulate yet 
melanoma metastasis process as a whole, however, the present engineered 3D tissue 
represents a reliable model for investigating the phenotype and behavior of melanoma cells 
derived from primary sites. Indeed, the 3D melanoma skin model is suitable to study the 
biological properties of radial growth phase invasion. This study represents a preliminary 
model for investigating all aspects of melanoma metastasis and it has great potential for 
improving our understanding of the interactive biology between melanoma cells and their 
immediate surroundings and evaluating melanoma cells influence on epidermis structure and 
differentiation.  
In conclusion, the present 3D engineered skin model represents a valid platform to study scar 
formation and a valuable tool for studying healthy and disease skin 10,11 or for screening test in 
vitro. Moreover, this platform could provide an in vivo skin substitute in clinical applications 
5,12,13. 
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1 Tissue engineering and Skin tissue engineering – in vivo and in 
vitro applications 
1.1 Tissue engineering: an overview 
The terminology ‘tissue engineering’ was officially coined at a National Science Foundation 
workshop in 1988 to mean ‘the application of principles and methods of engineering and life 
sciences toward the fundamental understanding of structure-function relationships in normal 
and pathological mammalian tissues and the development of biological substitutes to restore, 
maintain or improve tissue function’ 1. Tissue engineering is a radically new concept for the 
treatment of disease and injury and consists in a multidisciplinary discipline that involves 
biology, medicine, and engineering 2. This science born to improve the health and quality of 
life for millions of people worldwide by restoring, maintaining, or enhancing tissue and organ 
function 3. In addition this science can have diagnostic applications by developing of in vitro 
tissue for testing drug metabolism and uptake pathogenicity 4. The foundation of tissue 
engineering for either therapeutic or diagnostic applications gives possibility to exploit living 
cells in a variety of ways. For this reason, it has been necessary to generate structures that 
mimic the intricate architecture and complexity of native organs and tissues. With the desire 
to create more complex tissues with features such as developed and functional 
microenvironments, cells-cells and cells-matrix communications and tissue specific 
morphology, tissue engineering techniques are beginning to focus on building modular 
microtissues with repeated functional units 5 6. This science evolved from the field of 
biomaterials development and refers to the practice of combining biodegradable scaffold, cells 
and molecules into functional tissues 7.  
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1.1.1 Classical approach 
Classical strategies of tissue engineering employ a “top-down” approach in which cells are 
seeded on a biodegradable polymeric scaffold. In top-down approaches, cells populate the 
scaffold and create the adequate extracellular matrix (ECM) and microenvironment often with 
the aid of growth factors 8, perfusion 5 and mechanical stimulation 9. One of the first rules to 
induce formation of adequate microenvironement are the use of biomimetic and 
biodegradable scaffolding and the use of structural features on the microscale to build 
modular tissues that can be used as building blocks to create larger tissues 5. However, 
despite advances, top-down approaches often have difficulty recreating the intricate 
microstructural features of 3D-tissues. Indeed, this approach – to produce viable tissue by 
seeding cells into preformed, porous, and biodegradable scaffolds – presents several 
problems mainly due to the difﬁculty in reproducing, adequate microenvironmental conditions 
in a three-dimensional (3D) thick structure 10 11.  
 
1.1.2 Bottom up approach  
An innovative modular approach was proposed to resolves typical problems of top-down 
approaches and to recreate the intricate microstructural features of tissues. This approach 
builds tissues by assembling blocks mimicking those units in a bottom­up 5. The fabrication 
of those tissue models necessitates tools to create an initial architecture and to systematically 
manipulate their microenvironments in space and time 12. Once obtained microtissues, these 
multicellular spheroids spontaneously aggregate and self-organize and can be used as 
building blocks to create larger scaffold-free tissues 5 13. One of the major challenges of this 
method is to assemble modular tissues with specific micro architectures into macroscale 
biomimetic engineered tissues. Despite this approach allows possibility to print complex 
tissues with high shape resolution, their use is limited by lack of mechanical integrity of the 
cellular aggregates that restricts the size of the resulting tissues. In addition to cell 
aggregates, the microtissues used as building units include cell-laden microgels 5, cell-seeded 
microbeads 14, and cell sheet 7. However there is a strong biological basis for this bottom-up 
approach as many tissues are comprised of repeating functional units, such as the lobule in 
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the liver 5. By mimicking native microstructural functional units, bottom-up approaches aim to 
create more biomimetic engineered tissues. One of the major challenges by using this 
approach is to assemble modular tissues with specific micro architectures into macroscale 
biomimetic engineered tissues 15 16. Other challenge is to retain the microarchitecture and 
cellular behaviour of modular tissues, and at same time, to create engineered tissues with 
robust mechanical properties. Figure 4 show an example of bottom-up methods witch 
microscale building blocks can be assembled into larger construct realized by various 
technology as: soft lithography 17, photolithography 18, membrane technology 19, centrifugal 
casting 10, micromachining 20, or the combination of multiple processes 21. Moreover, 
combination with computer-aided printing systems helps generation of appropriate and 
complex 3D-templates. Designs must focus on promoting itself-remodelling into the final 
architecture. Usually these building blocks composed by gel encapsulated cells 16 or 
spontaneously aggregated cells 22. Microbioreactors are other important makers of this 
approach, Indeed, presence of microbioreactors allows long-term control of microscale tissue, 
formation of adequate microenvironement and accurate control of amounts of biological 
factors and relate gradients 18 23 15. The primary advantages of this method are the rapid 
production of millimetre-thick 3D cell structures, a homogeneous cell density, a tissue 
formation without necrosis in a period of less than a week and the possibility. to culture 
microtissues in controlled, heterogeneous environments 2425  
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Fig. 1: Bottom-up & Top-down approaches to tissue engineering. In the bottom-up approach there are multiple methods for creating modular 
tissues, which are then assembled into engineered tissues with specific micro-architectural features. In the top-down approach, cells and 
biomaterial scaffolds are combined and cultured until the cells fill the support structure to create an engineered tissue 8. 
1.2 Human skin and engineering skin tissue 
The skin is the largest organ in mammals with a total area of about 20 square feet and has a 
surface area of 1.5–2.0 m2. Skin plays a primary role in protecting the body from mechanical 
damage and his first role is to create a protective barrier at the interface between the human 
body and the surrounding environment in order to protect the body against toxins, pathogens 
and external microorganisms 26. Moreover the skin helps regulate body temperature, allows 
the sensations of touch, heat, and cold and receives sensory stimuli from the external 
environment 27. The skin consists of three layers of tissue: epidermis, dermis with a complex 
nerve and blood supply, and hypodermis composed mainly of fat and a layer of loose 
connective tissue. At cellular level, cell types are various (Fig.2) 2. The barrier function of the 
skin is provided by its avascular epidermal layer, which is composed mainly of keratinocytes: 
a-nuclear keratinocytes product keratin and form the surface barrier layer. Melanocytes are 
found in the basal layer of the epidermis and provide skin colour by production of melanin. 
Fibroblasts are the first cell type present in dermis and provide strength and resilience to 
stroma 26. 
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Fig. 2: The epidermis, dermis, and subcutaneous tissue are the three layers that compose the human skin 
In the past 30 years, great efforts have been made to create substitutes that mimic human 
skin 28 and different researches were born by evaluating different aspects of skin and studying 
all types of cell behaviour. Indeed, engineered human skin models designed require the ability 
to fabricate tissues that faithfully mimic the in vivo counterparts to advance our understanding 
of human disease processes 26. These artificial skins have been used for clinical applications, 
promoting the healing of acute and chronic wounds, to study skin diseases, to shown that 
cell-cell interactions during early cancer progression and for in vitro studies as screening 
platform 2 26. Thus skin substitutes were used both for clinical application promoting in vivo 
repair by their use as in vivo grafts, than for in vitro test systems 29. In this perspective, 
engineering skin (ES) tissue born as valid alternative to use of animal models. Animal models 
provide valuable translational vehicles for human treatment modalities and disease 
investigations. However, because there are differences between animal skin and human skin 
development 26, as for example aberrant scars are specific to humans, the extrapolation to the 
human situation and development of an animal model has been extremely difficult 30. The 
major difference between laboratory animals and humans are differences in the metabolism, 
different anatomical architecture compared to human skin and the presence of the panniculus 
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carnosus in animals, a fibromuscular layer enabling the skin to slide over underlying fascia 31. 
In addition, ES are a valid alternate to in vitro 2D-monolayer cultures of human cells because 
of the lack of complex cell-cell and cell-ECM interactions 32. Most tissue-engineered skin is 
created by expanding specially keratinocytes in the laboratory (at a rate much greater than in 
vivo happened) and using them to restore barrier function (the primary objective for burns 
patients) or to initiate wound healing (for chronic non-healing ulcers) or to study skin disease 
development (such as in melanoma evolution) 27 33 (Fig. 3). Other uses include accelerating 
healing, reducing pain and correcting conditions in which healing has been suboptimal (for 
example, in scars or pigmentary defects), investigate malignant differentiation of epithelial 
cells and the in vitro use as screening platform for emerging drugs testing 34 27. Keratinocytes 
were first reliably cultured in the laboratory about 40 years ago 35. This developed into the 
production of small sheets of cells three or four layers thick 36 (known as cultured epithelial 
autografts, CEAs). Keratinocytes are an ideal alternative treatment for large burns, instead of 
skin grafting. Since then, numerous clinical trials have demonstrated the efficacious 
application of cultured keratinocytes during wound repair process 37 2. However, due to lack of 
dermal structures, simple keratinocyte coverage is fragile and the take rate varies depending 
on the condition of the defected area. To improve an increase of survival 38 and proliferation 10 
rate of keratinocytes, fibroblasts were used 2. Fibroblasts are the second class of cells using 
by skin tissue engineering, are dermal cells plays an important role in the wound healing 
process by producing extracellular matrix (ECM) proteins and cytokines 39 25. Fibroblasts 
behaviour was investigated by introduction of artificial dermis or exogenous collagen and they 
have been incorporated into a three-dimensional scaffold, where these cells could secrete 
and organize an extracellular matrix 40 41. In this perspective it must be consider three factors 
for the development of tissue-engineered materials: the safety of the patient, clinical efficacy 
and economic convenience of use 42 43. Any cultured cell material, as the use of bovine or rat-
tail collagen, carries the risk of transmitting viral or bacterial infection, and may also have a 
disease risk 33. There must be clear evidence that tissue-engineered materials provide benefit 
to the patient and disease risk must be eradicated. In the light of that, significant progress has 
been made over the last years in the development of in vitro-engineered substitutes that 
mimic human skin, either to be used – without infection risk – as grafts for the replacement of 
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lost skin or for the establishment of human-based in vitro skin models. Moreover, tissue-
engineered human skin equivalents (HSEs) have contributed significantly to the 
understanding of biological processes and skin diseases 44–46  This human tissue model 
recapitulates the morphology of skin to a large degree and has facilitated further clarification 
of different cellular roles for a normal epidermal/dermal morphogenesis. Moreover these 
optimally-engineered human tissues has been adapted to study a variety of human disease 
processes that simulate events that occur in human skin and other stratified squamous 
epithelia. As examples is how SE cultures have been used to characterize the response of 
human skin-like tissues following wounding and during early cancer development in a 
premalignant tissue 8 47. Indeed the presence of a 3D-structure involves interactions between 
cancer cells and their microenvironment and create a context that promotes tumour growth 
and consequently, a good context were study cancer progression and related mechanism 48 27 
49 14.  
 
Fig. 3: Schematic illustration of principles of skin tissue engineering. Primary keratinocytes and fibroblasts are isolated from human donor 
tissues, which are then in vitro expanded prior seeding onto suitable scaffold materials/matrices. For a full-thickness skin equivalent, the 
fibroblasts and the matrix are initially used to establish the dermal part. The keratinocytes are seeded afterwards on the top of the dermis to 
ultimately form the epidermal part of the skin substitute. The in vitro-engineered skin can serve as skin graft or can be used as human-cell 
based in vitro test system. 
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1.2.1 Human skin: epidermis 
The outermost layer of the skin is the epidermis. It forms a protective barrier over the body's 
surface which prevents pathogens from entering. It is also responsible of skin turgor, body 
temperature regulation and for nutrients absorption. The epidermal barrier layer is relatively 
thin (0.1–0.2 mm in depth) and securely attached to the underlying dermis by a specialized 
basement membrane zone 50 (Fig.4). The major cellular population are keratinocytes. These 
cells consist of 95% of all epidermal cell population. These cells progressively differentiate 
from cells in the basal layer, which is located on the basement membrane and gives rise to 
daughter keratinocytes, to cells without nuclei which are pushed upwards and product sheet 
of keratin. These upper keratinized epidermal layers provide the barrier layer, which resists 
bacterial entry and prevents fluid and electrolyte loss. This cell behaviour provides epithelium 
stratification 51. Indeed, the epidermis can be subdivided into five layers: stratum basale 
(composed mainly of proliferative keratinocytes attach to the basement membrane); stratum 
spinosum; stratum granulosum (in this layer keratinocytes lose their nuclei and their 
cytoplasm appears granular); stratum lucidum; stratum corneum (this layer is full of keratin 
proteins). During development of epidermal layers, keratinocytes became anucleate, change 
shape  and become highly organized, forming cellular junctions (desmosomes) between each 
other and secreting keratin proteins that aid in protection from external factors  522. 
Melanocytes other non-epithelial epidermal cells and that provide skin pigmentation. 
Melanocytes are dendritic cells only found in the deepest layer of the epidermis. The basic 
features of these cells are the ability to melanin production. These cells form the epidermal 
melanin units as a result of the relationship between one melanocyte and 30-35 associated 
keratinocytes 53. The ratio of melanocytes to keratinocytes is 1: 10 in the epidermal basal 
layer. Melanocytes origin from neural crest cells (melanoblasts) and the life cycle of these 
cells consists of several steps including migration and proliferation of melanoblasts, 
differentiation of melanoblasts into melanocytes, maturation of melanocytes and subsequent 
melanin production 49. The embryonic development of melanocytes gives an opportunity to 
better understand the various skin diseases, for example melanoma and its heterogeneity. 
The precise mechanisms that control the organization and number of melanocytes in the 
epidermis are unknown 54 49. 
16 
 
 
 
Fig. 4: The structure of epidermis. The epidermal barrier layer is relatively thin and composed of four different layers. Epidermis attached to the 
underlying dermis by a specialized basement membrane zone 
 
1.2.2 Human skin: dermis and related components  
The dermis is the second layer of skin and varies in thickness depending on the location of 
the skin. It is 0.3 mm on the eyelid and 3.0 mm on the back. The dermis specially composed 
of a cellular component and extra-cellular component (ECM) with a specific 3D-structure and 
architecture (Fig.5). The ECM exists in several biochemical and structural forms and is 
secreted and assembled by cooperative activity of numerous cell types for the formation of 
stroma 55. The major cell population are fibroblasts. The ECM 3D-structure and its different 
components can signal specific information to fibroblasts and modulate cell migration into 
and within inflamed tissue, cell activation, proliferation and differentiation. Apart from these 
cells, the dermis is also composed of matrix components such as collagen (which provides 
strength), proteins, proteoglycans and glycosaminoglycans (GAGs), elastin and extrafibrillar 
matrix. This extra-cellular matrix (ECM) has a relevant role into dermis and each single 
component of ECM impart specific signal to cell that modulate basic function such as 
regeneration and maintenance of tissues and organs 56. Presence both cells than extra-
cellular components cause a relevant environment composed by an intricate 3D network of 
fibrillar proteins, proteoglycans and glycosaminoglycans (GAGs) (Fig). The major component 
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of ECM is collagen: it is the main component of connective tissue. Currently are identified 
more than 20 genetically different types of collagen 5758 59. Collagen molecules consist of three 
polypeptide A chains, each of them containing at least one repeating Gly-X-Y sequence, 
where X and Y are usually proline and hydroxyproline, respectively 58 55. All hydroxylation and 
glycosylation are post-translational modifications. The three chains are supercoiled around a 
central axis in a right-handed manner to form a triple helix. By a crosslinking mechanism, 
collagen molecules self-assemble into collagen fibrils to generate large amount of collagen 
fibers and consequently, collagen bundles. Depending on their structure and supra-molecular 
organization, collagens can be classified into fibrillar (accounting for 90% of all collagens) and 
non-fibrillar collagens; these two collagen components involve in different characteristics to 
connective tissue. For example, fibrillar collagens provide torsional stability and tensile 
strength. In contrast, basement membrane collagens such as collagen type IV are more 
flexible, giving the basement membrane its typical characteristics 60. In general, collagens are 
mainly seen as structural proteins although they contain small sequences responsible for 
binding to cellular receptors. Other extra-cellular skin components are fibronectin (it is the 
second most abundant protein in ECM) witch are responsible for cell adhesion; elastin witch 
give to skin the ability of transiently stretching; GAGs witch are responsible for increase in 
tissue stiffness as they act as water pumps under mechanical loads; and laminin as first 
component of basal membrane 57. Moreover ECM plays a critical role in successful tissue 
engineering as well 61. 
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Fig. 5: The structure of human dermis. Dermis consists of several different types of collagen fibre, which attach cells securely to the underlying 
dermis, and is visible at the electron-microscope level. The dermis varies in thickness depending on its site in the body and is composed 
primarily of collagen I, with dermal inclusions of hair shafts and sweat glands, which are lined with epidermal keratinocytes. The dermis is well 
vascularized and also contains receptors for touch, temperature and pain. 
 
1.3 In vivo applications 
Necessity to use engineered skin in clinical applications born when physiological in vivo 
process doesn’t restore normal physiognomy of tissue. There are numerous reasons for skin 
damage including genetic disorders, intense trauma, chronic wounds, inadequate immune-
response or surgical interventions 26 62 One of the most common causes for major skin injury 
is thermal trauma specially when the affected area of skin is too large and therefore cannot 
be successfully treated with conventional techniques with consequently death of the patient 
or a chronic ulcer formation 63. Although autologous skin grafts remain the first option in the 
current standard of care for burn patients, there are clinical circumstances where using the 
donor’s own skin might not be optimal above all because problems associated to the quantity 
of tissue damaged. For this reason tissue engineering is even more relevant in this context. 
Skin substitutes are artificial skin replacement constructs that provide the protective barrier of 
the skin when placed over acute burn injuries or other chronic skin wounds such as 
cutaneous ulcers and congenital anomalies 64 65. Their first objective is to work as skin 
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equivalents, facilitate repair, and restore the functional loose properties of skin. Indeed, the 
production and the use of skin substitutes have led to dramatic improvements in the odds of 
survival for severely burned patients, and in the cases of chronic wounds. Several reviews on 
many different products have appeared in the scientific press over the last few years and an 
extensive body of literature exists on the experimental and clinical use of epidermal/dermal 
replacements 63 34 26 62. These skin substitutes can have different roles indeed they can act 
both as temporary wound covers than permanent skin replacements, depending on their 
design and composition. The main advantage of using engineered skin constructs is that they 
reduce or eliminate the need for donor site area, which is required for autologous split-
thickness grafts. Nowadays more than 20 products have actually commercially available for 
clinical trials and use as adequate grafts 66. According to literature, skin substitutes can be 
divided by using several criteria: dermal versus full skin substitutes, biological and synthetic 
scaffold, acellular or cellular materials and substitutes based on allogeneic or autologous 
cells. At moment, many current products do not contain any living cells and vary in their 
capacity to harness the innate capacity of the body to heal itself 62 67 64. Only recent 
engineered grafts include living cells with allogeneic or autologous origin, and are often 
referred to as ‘cellular therapy’ or ‘tissue-engineered’ products. The most commonly products 
that are being used at moment, for wound treatment are: Epicel® and Epidex® as epidermal 
platform; Biobrane™, Integra™, Alloderm™ Oasis® and TransCyte™ (in different conservation 
techniques) as acellular dermal platform, Dermagraft®, Apligraf® and Hyalograft® as cellular 
dermal substitutes and Apligraft™ and Orcel™ as available full-thickness constructs. Manly 
engineered construct are reported in table 1. All principles and characteristics of various skin 
substitution and relevant materials have been described already some decades ago in 
different reviews 67 26 63 34. In general, the majority of researches focus on the ability to allow 
epidermal coverage to restore barrier function of the skin and the presence or influx of cells 
that will function as dermal cells and produce dermal tissue rather than scar tissue. At 
present day, dermal substitutes function as an optimized wound bed to support outgrowth of 
keratinocytes, or from an epidermal component such as a skin graft or an artificial epidermal 
component containing autologous or allogeneic keratinocytes 40. Despite developments in 
available skin substitutes, there are several limitations and various aspects witch involve 
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several problems in the clinical therapeutic collection such as reduced vascularization 36, 
scarring 62, failure to integrate, poor mechanical integrity 34 and immune rejection 1. Indeed, a 
perfect graft should be easily available, afflict no immune response, cover and protect the 
wound bed in sterile condition, enhance the healing process, lessen the pain of the patient 
and result in little or no scar formation 26. Despite recent development, for example, proper 
wound bed preparation, including cleaning, debridement and attention to aseptic conditions, 
must be conducted in a meticulous and timely fashion in order to obtain the best possible 
clinical outcome and to minimize number of infections (but not for completely avoid them) 27. 
Moreover, despite this evidence, a relevant limit is the inability to avoid scar formation after 
the use of epidermal/dermal substrate in vivo applications. In vivo, it was shown that the 
presence of fibroblasts in the dermal matrix appears to inhibit migration of other 
mesenchymal cells but may also control fibroblast migration into the wound bed also evidence 
proves that a fibroblast-seeded matrix improves scar contraction in a cell number-dependent 
fashion in porcine full-thickness wounds 31 30 68 69. Moreover, it has been reported that wound 
contraction and scar formation in an in vivo model could be prevented with a responsive 
substitute dermal matrix seeded with skin cells. Fundamental research into wound healing 
and scar-free regeneration raises the hope that we will eventually be able to restore almost 
completely the appearance and function of skin after a grafting 70. 
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Table 1: commercially available in vivo epidermal and full-thickness skin substitutes 
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1.4 In vitro applications 
During the last decade, human in vitro skin models has been developed as valid alternative to 
current study models and to mimic human skin,. At moment use patients and animal models 
are two defective alternatives to recapitulate disease processes and test innovative drugs. The 
possibilities to use patient as in vivo models are limited, due to obvious ethical considerations 
71. Current and common alternative is the use of animal models 31. Despite the large number 
of studies describing mice, pigs, rabbits, rats and other animals as models to investigate 
various phenomena – such as cellular behavior, tissue contraction, evaluation of drugs 
absorption, reepithelialization process during wound healing, UV treatments, scar and 
hypertrophic scarring phenomena –,  these processes presents significant differences in these 
species and it is extremely difficult compared with human tissue specially because of lack of 
specific biomarkers, differences in skin structure and physiology 72 73 74. Moreover, with 
increasing pressure from the EU (Directive 2010/63/EU) and the introduction of 3R-principles 
“replace, reduce and refine” for the use of animal models, there is an urgent need to develop 
a physiologically relevant and responsive in vitro human wound model to investigate the skin 
response and the pathogenesis of tissue 75. In skin TE, various biological and synthetic 
materials are combined with in vitro-cultured cells to generate functional tissues. For several 
years, two dimensional (2D) in vitro monolayer cultures of human cells were use but these 
platforms are low relevance due to the lack of complex cell–cell and cell–ECM interactions 76. 
For example it must be kept in mind that the actual wound environment is infinitely more 
complex than the environment inside a Petri dish. In this way, novel in vitro ES are enables 
not only the investigation of fundamental processes in the skin, but also the hazard 
assessment of various chemical compounds that are topically applied on the skin. Presence 
of a 3D physiological environment, allows the interaction of the different cell types with one 
another and the surrounding matrix. This peculiarity, also help to elucidate fundamental 
processes in the skin such as the stimuli that lead to the formation of the epidermis 26 77, the 
molecular cross-talk between different cell types both in normal than pathological conditions 
16 78, the process of wound repair 79, the maintenance of the stem cells 80, and the infection 
with different kinds of toxins and microorganisms 67. Moreover the cellular composition is 
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completely controllable by the researcher in these conditions. First developed models focus on 
reepithelialization phenomena and allow possibility to study pathologies and drugs effect only 
at epidermal level 81. Keratinocytes behaviour can be investigated followed by UV radiation or 
physical damage 82. The rapid reestablishment of the epidermal barrier function after a skin 
defect is vital for preventing wound infection and restoring homeostasis to the wound area. 
Natural biological scaffolds often retain the natural basement membrane and can therefore 
produce a valid and full differentiated epidermis when cultured with keratinocytes 83 84. A 
fundamental aspect that can be evaluated is the differentiation of keratinocytes into a 
complete stratified epidermis with all the different strata found in native epidermis. In this 
perspective care should be taken in selecting the source of the keratinocytes 85. Regarding 
skin irritation tests, presence of a 3D microenvironement is also important for the 
measurement of cytotoxicity, and for metabolic reactions such as cytokines and enzyme 
release. In response to physical or chemical stresses, keratinocytes release various 
substances such as different interleukin (IL-1 α, IL-8, IL-6, IL-7, IL-15, TNF-α) 86. 
Employing in vitro skin substitutes, a dose dependent release of the cytosolic enzyme lactate 
dehydrogenase (LDH) and IL-α was observed in response to the application of various drugs 
and cosmetics 26. However many drugs and cosmetics are applied to the skin, but the amount 
of the substances that reach the targeted site remains often unclear. Fibroblasts are another 
important cell type evaluated during skin alterations 78. These cells have only recently begun 
to receive more attention. At moment, the engineering of skin substitutes can allow for the 
fabrication of biological constructs for various pathologic conditions like disease evolution with 
stroma alterations, burns or cutaneous ulcers 26 48. The importance of dermal components and 
mesenchymal cell to the SE is increasingly being recognized. Recent developments showed 
that a dermal component can accelerate the reepithelialization process and that greatly 
improve the outcome of the pathological process in an in vitro SE 34. Moreover, recent studies 
have been demonstrated that the addition of a dermal matrix can also improve scar 
contraction in a dose-dependent fashion when applied to full-thickness wounds 87. The 
currents SE are cultured at an air-liquid interface a synthetic or on a collagen matrix that 
could be acellular or populated with dermal fibroblasts. Porous membranes seeded with 
fibroblasts or coated with extracellular matrix proteins (as hyaluronic acid or fibrin) have also 
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been used to generate skin-like organotypic cultures 88 76. A few investigation and optimization 
were carried out to fabricate and maintain a stratified epithelium that demonstrates in vivo-
like features of epidermal morphology, growth and differentiation, in 3D-cultures. To induce all 
of that, three components were developed: presence of keratinocyte stem cells with high 
proliferative potential, viable dermal fibroblasts and structured basement membrane 89. For 
keratinocytes question, different cellular lineage has a relevant influence about a good 
epithelium development. Dermal fibroblasts are required to promote stratification and it was 
demonstrated that fibroblasts play a crucial role in the natural epidermal histogenesis 90. 
Indeed keratinocytes/fibroblasts interactions are crucial to improve formation of a valid 
epithelium and co-culture studies with keratinocytes reveal that post-mitotic fibroblasts 
stimulate keratinocyte proliferation, increase the resistances of keratinocytes to toxic 
chemicals and induce a higher secretion of keratinocyte growth factor (KGF) 91 44. 
Interestingly, keratinocytes have also a positive effect on the proliferation of fibroblasts due a 
biochemical processes. Indeed it was hypothesized that this interaction of epidermal and 
dermal cells is due to a double-paracrine mechanism that regulates the growth of 
keratinocytes and fibroblasts 92 93. According to this hypothesis, keratinocytes secrete IL-1 that 
stimulates the skin fibroblasts to secret KGF and granulocyte-monocyte colony-stimulating 
factor (GM-CSF), consequently higher keratinocytes proliferation results 33. Third, the 
presence of pre-existing basement membrane components was required to initiate and 
promote the rapid assembly of structured assembly BM in 3D-cultures and optimize epithelial 
architecture 94. To date, many types of skin substitutes – with or without a dermal component 
– have been developed and commercially available by different groups 95 26 96.The main 
competitors in this market sector are Skinethic™ RHE, Episkin™ (SkinEthic/ L'Oreal 
corporation, France), Epiderm™, Epiderm FT™ (MatTek Corporation, USA), EST-1000, and 
AST-2000 (Cell-Sytems corporation, Germany). In table 2 shows the main characteristics of 
these SE. At moment, optimally-engineered human tissues can be adapted to study a variety 
of human disease processes that simulate events that occur in human skin. Typical 
applications are: studies on human disease 97, investigation of hypertrophic scar and keloids 
formation 30, characterization of human skin-like tissues response following wounding 98 or 
during early cancer development in a premalignant tissue 12. It has been demonstrated that 
25 
 
presence of 3D- architecture is crucial to development of adequate microenvironement that 
mimic in vivo situation. Indeed, preliminary studies – that have utilized these 3-D tissues – 
have demonstrated the critical role of tissue architecture and cell–cell interactions during: the 
earliest stages in the development of cancer in stratified squamous epithelium 99. Moreover, 
the importance of these 3D-structures was confirmed by studies on reepithelialization process 
of wounded human skin – from the initiation of keratinocyte activation until restoration of 
epithelial integrity. 2 At least these SE models have a higher responsivity to cells behaviour 
after wounding, in terms of growth, migration, differentiation, and growth-factor production. 
Thus, all these studies and applications demonstrate the benefits of these engineered skins in 
the study of skin alterations. Despite the big innovation in SE realization and studies, relevant 
problems are already detected. The extensive cell culture procedures imply that development 
of tissue engineered skin is time consuming. Indeed procedures usually require two or three 
weeks to obtain full-thickness in vitro models. This results in an increased turn over period for 
production of tissue engineered skin, which is a constraint for its regular use, and could be 
overcome, with technical advances in cell and tissue culture protocols 100 101. Moreover to 
data, tissue engineered skin aren’t a circulatory system and contain only two or three cell 
types as fibroblasts, keratinocytes and melanocytes or cancer cells: Langerhans cells, adipose 
tissue, monocytes, leukocytes and nerve supply are absent 102 2. Hence, these substitutes are 
unable to provide immune regulation, adequate temperature control, insulation and pressure 
sensation 34. 
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Table 2: commercially available in vitro epidermal and full-thickness skin substitutes 
 
 
1.5 Disease skin models 
1.5.1 In vitro wound healing models 
The human skin functions as a protective physical barrier against the outside and any break 
in it must be rapidly and efficiently repaired. In case of physical skin damage – and 
consequently an interruption in tissue continuity – a complex series of events involved to 
restore the gap 65. Wound healing is a highly organized series of processes resulting in tissue 
integrity and function of the damaged tissue witch chemotaxis 103, cell division 104, granulation 
tissue formation 105, reepithelialization process 106, neovascularization 107, synthesis of new 
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extracellular matrix 108, formation and remodelling of the scar tissue are involved 109 110. This 
process needs a complex microenvironement to be studied. Thus, to study the wound healing 
process in detail, the development of in vitro wound model systems is important. To date, 
most of 3D-engineered constructs were focus on repair mechanism investigations and all in 
vitro alternatives can easily be manipulated and are cost-effective compared to in vivo 
systems 67 27 30. Of course, an ex-vivo skin cultures and monolayer cell culture assay are 
already widely studied but ethical problems and complexity of process – that cannot be 
reduced merely to cell migration – respectively, limit their use 111 112 83. A 3D architecture is 
necessary to better understand repair mechanisms. Typical examples of 2D in vitro models 
involve use of a scratch assay, in which a confluent cell-monolayer is scratched with a tool 
such as a pipette cone or a razor blade, so as to mechanically remove a ‘‘strip of cells’’ from 
the monolayer 10385,103,113–116. This method is based on the observation that, upon creation of a 
new artificial gap, or ‘‘scratch’’, the cells on the edge of the wound will move toward the 
opening to close the ‘‘scratch’’ until new cell–cell contacts are established again. Time-Lapse 
analyses – at the beginning and at regular intervals during cell migration – are crucial to follow 
closure phenomena and to determine the rate of cell migration 113–115. These methods largely 
used to mimic in vivo migration of different cell types. An example are wound model assays 
were scratch of endothelial monolayer induces migration of endothelial cells (ECs) into the 
denuded area to close the wound 85. Furthermore, the patterns of migration either as loosely 
connected population (e.g., fibroblasts) or as sheets of cells (e.g., epithelial and HaCat) also 
mimic the behavior of these cells during migration in vivo. Moreover, these in vitro scratch 
assays allow possibility to evaluate regulation of cell migration by cell interaction and cell 
contraction 116 117 118 . Recently have been demonstrated that for cells adhering to their 
substrate, and despite the presence of a contractile peripheral actomyosin cable at the free 
edge, the final stages of closure of wounds larger than a typical cell size result mostly from 
protrusive lamellipodial activity at the border. In that case, the function of the actin cable 
appears to be primarily to prevent the onset of migration fingers led by leader cells 114,116 at the 
free edge. Thus by using 2D in vitro scratch assay, mechanical basis such as measure cellular 
forces during epithelial gap closure was been studied. These studies revealed one class of 
closure that involves covering a bare surface in which leading cells in an advancing epithelial 
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monolayer migrate across the surface in an adhesion-dependent manner 85,115,116. Across non-
adhesive gaps, epithelial cells employ a different mechanism by generating traction forces 
parallel to the wound margin through the contraction of a multicellular actin purse string to 
close the wound 116. Despite these mechanisms explain many aspects of reepithelialization, it 
is unclear how these findings relate to repair of fibrous tissues wherein mesenchymal cells 
ensconced in a fibrillar matrix restore the the 3D architecture of the tissue. Furthermore 
evaluation of epithelial differentiation and stratification, cell-cell and cell-matrix interaction, 
formation of provisional matrix and collagen behaviour can’t be evaluated 19,119. In this 
perspective only 3D wound-healing models can systematically and quantitatively 
characterized allowing the investigation of responses induced by different stimuli. There are 
several approaches of inducing a physical damage including burning, freezing, scratching, 
abrading or punching the epithelium 2779 The most commonly used instruments to induce 
injury are scalpels, biopsy punches, lasers, liquid nitrogen or burn injury at 150° C  79 120 79. 
All these methods allow reproducible wound gap and can produce wounds of exactly 
dimensions and depth. A reproducible wound method is crucial for determining in vitro re-
epithelialization and evaluate epidermal closure-times; in details, this is precisely the central 
question debated in the literature during wound healing process 46,67,68,81,83,109,121–124. Figure 6 
reported principal examples of in vitro 2D and 3D platform to study wound healing. It has 
been proved that 3D wound models simulates the chronology of events that occur during 
reepithelialization in human skin and currents studies evaluated the mechanism of the 
creation and extension of the epidermal tongue. To data, two reepithelialization mechanisms 
were postulated: the first is the leap-frog or rolling mechanism in which migrating suprabasal 
cells roll over leading basal cells and dedifferentiate ; the second is the tractor-tread or sliding 
mechanism postulates that layered keratinocytes move forward in a block 81. Usui et al. (2005) 
proposed a variant of the sliding mechanism in which suprabasal cells migrate out of the 
wound, thereby outnumbering the basal cells 125. It has up till now been unclear whether one 
of these mechanisms is correct and how such a mechanism is functionally embedded in the 
environment of the wound. 
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Fig. 6: Schematic example of typical 2D and 3D in vitro model to study wound healing: in A reported typical 2D scratch assay to 
evaluate epithelial gap closure 115; in B reported a schematic microtissue device to study fibroblasts behaviour during repair 124, in C 
reported classical 3D in vitro model to study reepithelialization process 126 
 
 
As well as in vivo applications and substitutes, in vitro 3D models can be divided into different 
groups. At the beginning there was 3D wound models with only epidermal components, full-
thickness in vitro models are born in the last years. All in vitro skin models induces a 
multilayered differentiated epidermis similar to native skin, expressing all the morphologic 
markers of epithelial differentiation 7. Indeed, these models constitutively express the keratin 
(K) markers such as K10, K14, K5, K19 and also differentiation markers as Involucrin and 
Filaggrin and p53 127 128 129. The presence of fibroblasts in these skin models have been shown 
an epidermal architecture more closely resembles to in vivo tissue due to production of ECM 
proteins and TNF-α and KGF expression 26,130 26. Human mesenchymal stem cells (MSCs) 
are another cell population that improve wound healing. MSCs derived from the stroma of the 
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bone marrow, are progenitor cells that give rise to many mesenchymal-derived tissues/cells 
both in vivo than in vitro and have been implicated in wound healing making them a potential 
candidate for cell-based bioengineered products for injured tissue. In vitro, these pluripotent 
cells have been shown to contribute towards cutaneous wound repair both in acute and 
chronic wounds 80,122,131. One in vitro study using co-culture conditions demonstrated that 
MSCs contributed to reepithelialization by both transdifferentiation and fusion, indicating that 
they may not be mutually exclusive events 80. It has been hypothesize that the use of human 
MSCs in the place of fibroblasts may also contribute to wound healing and provide an 
effective method for wound closure 80,83. Another important parameter evaluated during wound 
healing studies is cellular contraction and fibroblasts behaviour after an injury. During an in 
vivo repair process fibrin clot serving as scaffold to induce fibroblasts migration and 
differentiation to induce tissue contraction and gap closure 132–134. Indeed, the development of 
mechanical stress by injury, stimulates fibroblasts to develop stress fibres so they acquire the 
proto-myofibroblast phenotype that secrete transforming growth factor β1 (TGF-β1) and in 
a feedback loop, proto-myofibroblasts become differentiated myofibroblasts by synthesizing 
α-smooth muscle actin and generating increased contractile force in a process of 
remodelling results in shortening of the collagen matrix with wound closure 87,135–137. The role 
of myofibroblasts in tissue contraction and ECM production and reorganization is an example 
showing the crosstalk between ECM and cells 137. Recently, Christopher Chan (2015) 
demonstrated that fibroblasts close the open gap through the coordinated action of force-
dependent contraction of the whole tissue, circumferential cell migration around the wound 
edge and assembly of fibronectin scaffolding 124. These kinds of studies understand how the 
role of stroma is relevant to correctly evaluate cells migration, matrix contraction and ECM 
remodelling during a wound healing process. Thus, combination both epidermal than dermal 
component are the only valid models to better understand repair process. Dermal 
components are mainly based on chemical analogues of extracellular matrix (ECM) such as 
exogenous collagen, or hyaluronic acid, or fibrin matrix 2,106,133,134,138–142. The main difference into 
full-thickness 3D wound model is matrix and scaffold used as dermal platform. These 
exogenous matrices can be acellular or may be cultured in vitro with fibroblasts 102,143. 
Examples of dermal in vitro platforms are: de-epidermized dermis (DED) 80, epidermis 
31 
 
reconstructed on de-epidermized dermis (RE-DED) 84, collagen lattices contracted with 
dermal fibroblasts 144, microperforated hyaluronic acid scaffold (Hyalograft®) 26, bovine 
collagen gel seeded with human hypertrophic and keloids fibroblasts 31,145, provisional 
cellularized matrix of fibrin (ICX-SKNTM) 95, fibroblasts/ keratinocytes/ monocytes/ 
mesenchymal stem cells in a 3D fibrin construct  146, 3T3 fibroblasts embedded in a type I 
collagen matrix 124, hypertrophic and keloids cells into a sponge-like collagen-elastin- matrix 
(MatridermTM) 147. Strong example of full-thickness organotypic cultures is ApligrafTM. This 3D 
wound model composed of allogeneic neonatal fibroblasts and keratinocytes grown on a 
collagen lattice and study many wound processes such as epidermal proliferation and 
differentiation, epithelial/mesenchymal interactions, and basement membrane production 
80,143,148. Recent new platforms are emerging to evaluate a further process occurred during 
repair: scar and abnormal scar formation. Scarring occurs after trauma, injury or surgery to 
any tissue or organ in the body; abnormal scar represent a form of pathologic wound healing 
and due to an abnormal inflammatory component of the wound healing process 40,66,149,149. 
Currently, a few 3D tissue-engineered models exist to study scar and all of that avoid the 
main questions referring to why an adverse scar forms instead of a normotrophic scar and 
what causes a hypertrophic scar to form rather than a keloid scar 69,70,109,150. Also, it was 
investigated if there is a genetic predisposition of the individual and if the immune system is 
involved. This information is essential if we are to identify new drug targets and develop 
optimal strategies in the future to prevent adverse scar formation. Current 3D skin equivalent 
models have been described using hypertrophic or keloid fibroblasts in combination with 
normal skin-derived keratinocytes. Using a similar method, a fully differentiated epidermis 
constructed from keratinocytes isolated from abnormal scars on a fibroblast (healthy)- 
populated dermal matrix was able to exhibit a few characteristics of an adverse scar (e.g. 
dermal thickness, epidermal thickness, collagen I) and illustrated the role of keratinocytes in 
hypertrophic scar formation 30,36,44,144,147,151–154.  
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1.5.2 In vitro melanoma models 
Malignant melanoma is the most aggressive and most prominent cancer in the human 
population. Malignant melanoma develops in a multistep process starting in melanocytes in 
the epidermis 26. In this process, melanocytes loose contact to the surrounding keratinocytes 
and enter a radial growth phase. This radial growth phase (RGP) is followed by a vertical 
growth phase (VGP) Radial growth phase (RGP) melanoma cells proliferate and form nests in 
the epidermis, but do not invade the dermis. In this phase, cancer cells are incapable 
biologically of generating metastatic events. Conversely, VGP cells cross the basement 
membrane, invade and proliferate in the dermis. Subsequent step is metastatic (met) 
melanoma formation that rapidly invades deep into the dermal compartment until arriving into 
organs 155,156. Most studies of melanoma cell biology and anti-melanoma drug activity have 
come from work done with 2D adherent cell culture assays. Typical examples of 2D in vitro 
melanoma models involve use of cancer monocultures on plastic tissue culture plates 157,158. In 
the past has contributed significantly to increasing our knowledge of cancer biology and to 
stimulating research into the field of anticancer drug discovery and development 157–159. The 
principal advantages of such models are simplicity, convenience, and cost that they are pure 
and free from contaminating cells important for protein, RNA or DNA extraction 54. Usually 
2D-models can be use in pre-clinical research to delineate molecular mechanisms that drive 
melanoma growth and progression or to determine inefficacy of novel drugs indeed it is often 
the case that drugs that do not work in 2D cell culture have no effect in more realistic models 
too 4,147,160. However, cytotoxicity assays based on 2D cell cultures show important limitations, 
in particular, conventional 2D models are not capable of mimicking the complexity and 
heterogeneity of melanoma. Indeed these models do not take into consideration that 
melanoma cells do not grow in isolation 76,161–163. Instead they are oriented in a three-
dimensional space, establishing continuous dynamic interaction with the stroma, i.e., 
extracellular matrix and other cell types such as fibroblasts, endothelial cells or immune cells. 
This is often referred to as the ‘tumor organ’ 12 54. Consequently, numerous signals that govern 
different cellular processes are lost when cells are grown in 2D plastic substrata. 3D models 
represent an acceptable compromise between the lack of microenvironment and of 
complexity of melanoma in 2D cell culture and the great complexity of the in vivo animal 
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models 54. 3D cell culture methods confer a high degree of clinical and biological relevance to 
in vitro models. Tumor spheroids are one of the most common and versatile scaffold-free 
methods for 3D cell culture and provide an environment that more closely resembles the 
physiology of human malignant melanoma than previously available systems 11,158,164. Spheroid 
cultures are small aggregate of cells that grows free of foreign materials. In spheroid cultures, 
cells secrete the extracellular matrix (ECM) in which they reside, and they can interact with 
cells from their original microenvironment 12,160. The value of spheroid cultures is increasing 
quickly due to novel microfabricated platforms amenable to high-throughput screening and 
advances in cell culture. Depending on the researcher’s needs and on the method used, it is 
possible to obtain spheroids of any dimension. In particular, spheroids larger then 400–600 
µm in diameter are with characterized by an external proliferating zone and an internal 
necrotic zone core 165. This is likely due to the limited O2 11 and nutrient and metabolites 
availability 165. Melanoma spheroids are usually implanted into a collagen gel matrix to 
simulate vertical growth phase and to closely mimic in vivo architecture and complex 
microenvironment 86. Indeed, exploiting presence of spheroid’s proliferative and necrotic zone, 
these 3D-models recreates the oxygen/nutrient gradient with a hypoxic zone and a central 
necrosis as well as in vivo happened between melanoma cells and their stroma 54. In this way 
more realistic study of melanoma growth, invasion and drug response can be carried out. An 
advantage to use collagen gel is that can be easily manipulated to alter elasticity and 
stiffness. Typical 3D tumor spheroids derived from cell lines of early stage melanoma 
progression were poorly invasive, whereas the cell line derived from a metastatic stage rapidly 
colonized the entire collagen gel. The major applications of tumor spheroids models are in 
testing chemotherapeutic agents, in particular testing novel drug delivery systems 11,37, and 
mapping response to treatment evaluating reduction in melanoma nests 35, induction of 
apoptosis in tumor cells 164, percentage of cells in G0/G1 or cell cycle analysis 86. For example 
several BRAF inhibitors are currently being studied and tested such as the BRAF inhibitors 
RAF-265 (Novartis)166, PLX4032 (Plexxikon/Roche) and GSK2118436 (GSK) 166. These drugs 
were evaluated as targeting oncogenic BRAF with PLX4720 or PLX4032 resulted in inhibition 
of growth and invasion of 3D spheroids and caused tumor regression of melanoma xenografts 
167–169. The last class of in vitro melanoma models are diseased 3D engineered human tissues. 
34 
 
Combination both epidermal than dermal component are new reality to study melanoma 
development and tumoral infiltration. To obtain an in vitro melanoma engineered skin, artificial 
skin is rebuilt from isolated cell populations and composed of a stratified, terminally 
differentiated epidermal compartment of keratinocytes and melanoma cells, a dermal 
compartment, and a well established basement membrane deposited by skin cells (Figure 7) 
86,160. Coculture of epidermal keratinocytes and melanoma cells can be plated on dermal 
substitutes mainly consists of deepidermized acellular cadaveric human skin, Matrigel, or 
fibroblasts embedded in a matrix containing type I collagen of rat tail tendon 156,170–172; these 
dermal platforms can be enhanced with chitosan, chondroitin sulfate, hyaluronic acid or 
elastin 173. Figure 7 recapitulated principal examples of in vitro 2D and 3D platform to study 
melanoma process. 
 
 
 
Fig. 7: Schematic example of typical 2D and 3D in vitro model to study melanoma: in A reported typical aspect of spheroid and in B spheroids 
implanted into a collagen gel matrix to mimic VGP melanoma phase 86. In C reported 3D engineered melanoma models 156 
 
To test whether these skin equivalents are useful to study malignant melanoma in a 3D 
environment, several studies has been inserted cell lines representing different progression 
stages. In human skin reconstructs, melanoma cells from different stages of progression have 
the same properties as in the patients’ skin, i.e., cells derived from a melanoma in situ/RGP 
are unable to invade the dermis from the epidermis, whereas advanced primary (VGP) and 
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metastatic melanoma cells readily invade the dermis 89,171,172,174,175. For examples, it was 
proven, by S-100 protein stain, that VGP primary melanoma cells WM793 and WM115 
formed nests and clusters at the epidermal-dermal junction, and exhibited invasive growth 
into the dermis. Whereas WM793 VGP melanoma cells invaded the dermis in clusters with 
only a few individual cells preceding the cluster, WM115 cell invaded the dermis more 
individually 156. Thus, when metastatic melanoma cells were incorporated into skin 
reconstructs, they displayed rapid proliferation and aggressive invasive growth deep into the 
dermis 156,176,177. Accordingly, reconstructed skin more closely resembles histologically human 
skin in architecture and composition, with all major cell types represented in physiologically 
relevant ratios and with a true relation between malignancy nature of melanoma cells and 
their in vitro tissue infiltration. (Figure 3C) 54. A number of recent studies proved that the use 
of tissue-engineered skin as a 3D model of the invasion of malignant melanoma in vitro has 
great potential for further studying the biological characteristics of malignant melanoma and 
evaluating the efficacy of drugs. It has been demonstrated that vemurafenib, PLX4720 and 
roscovitine are capable of decreasing proliferation 167,168,173, inducing apoptosis in mutant BRAF 
melanomas 178,179 and in A375 melanoma cells 180 respectively Also, it has been reported 
reported that combinations of MAPK and AKT inhibitors completely suppressed invasive 
tumor growth of melanoma cells in a similar 169,179. Melanoma engineered skins has unique 
properties to create a complex in vitro tumor model which could be useful to study melanoma 
biology and progression, and to identify new pharmacological targets. 
 
 
1.6 The role of ECM-cells cross talking in pathological events: wound 
healing and melanoma 
In the skin, the interaction of keratinocytes, fibroblasts and melanocytes is tightly controlled by 
various factors and cascades 127. The microenvironment of each organ and tissue develops to 
specifically support the function of those cells: the ECM provides the structural scaffolding for 
these cells, as well as contextual information 2,55,162,181. Under normal conditions, there is a 
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balance between cell types via cell–cell contact and ECM. The normal extracellular matrix in 
the dermis mainly consists of type I and type III collagen, proteoglycans, fibronectin and 
elastin. In particular, collagen fibrils are important for the strength and resilience of skin, and 
alterations in their number and structure are thought to be responsible for wrinkle formation 
65,78,182. The disruption of these equilibria can result in an uncontrolled stroma degeneration (as 
involved in scarring)66,110 or uncontrolled proliferation of epithelial cells (as in malignant 
melanoma) 183,184. Wound healing is a highly organized series of processes resulting in tissue 
integrity and function of the damaged tissue; this process needs a complex 
microenvironement to be studied 47,185,186. Carcinogenesis is defined as complex, adaptive 
processes which are controlled by intricate communications between the host and the tissue 
microenvironment 48,187,188. Therefore it shows that the microenvironment and the stroma play 
an important part both in wound healing process than in tumour development and 
progression. Various examples of cell-ECM interaction are studied. The role of myofibroblast 
in ECM production and reorganization in wound contraction is an example showing the 
crosstalk between ECM and cells. Indeed, it has been demonstrated that during skin wound 
healing, a fibrin clot is formed in the wound bed serving as a scaffold, allowing migration and 
proliferation of dermal fibroblasts 107,185. The development of mechanical stress stimulates 
fibroblasts to develop stress fibres and to produce collagen, so they acquire the proto-
myofibroblast phenotype that secrete transforming growth factor β1 (TGF-β1) and in a 
feedback loop, proto-myofibroblasts become differentiated myofibroblasts by synthesizing α-
smooth muscle actin and generating increased contractile force in a process of remodelling 
results in shortening of the collagen matrix with wound closure 87,136,189. Another example is the 
role of N-cadherins in metastasis. N-Cadherin mediated homotypic aggregation among 
melanoma cells as well as heterotypic adhesion of melanoma cells to dermal fibroblasts and 
vascular endothelial cells in ECM to improve melanoma infiltration in malignant melanoma. 
Indeed malignant melanoma is characterized by alterations to the dermal connective tissue 
and relates underline stroma 190–192. The ECM represents a fundamental component of the 
skin, participating in the transport of biologically active substances needed for the 
communication between different cellular components and participating in the main important 
process occurring in skin disease. Consequently presence of ECM and appropriate studies 
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are necessary to better understand physiological and pathological processes occurring in 
human skin. 
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2 Engineered 3D human dermis model to study tissue repair in 
vitro: experimental set-up comparison  
2.1 Introduction 
2.1.1 In vivo wound healing process 
The SKIN functions as a protective physical barrier against the outside 1. Any break in it must 
be rapidly and efficiently mend: any perturbation of skin integrity can induce a number of 
pathologic conditions. In case of physical skin damage, a complex series of events involves to 
restore the barrier function of the skin. This efficient and complete process, named wound 
healing, include chemotaxis 2, cell division 3, granulation tissue formation 4, neovascularization 
5, synthesis of new extracellular matrix 6, formation and remodelling of the scar tissue 7 8. This 
dynamic and interactive process is classically divided into four overlapping but distinct stages: 
hemostasis (or early phase), inflammation, proliferation, and remodeling. Figure 1 
recapitulates first wound healing aspects. 
 Hemostasis The early phase is an immediate phenomenon, indeed it begins minutes  
after skin injury and manifested with tissue blanching and formation of a clot. The clot 
represents a viable, dynamic matrix of proteins and cells that not only contribute to 
hemostasis but also serve as a provisional lattice for incoming inflammatory cells, fibroblasts, 
and growth factors 6. It consists of platelets embedded in a mesh of crosslinked fibrin fibers 
derived by thrombin cleavage of fibrinogen, together with smaller amounts of plasma 
fibronectin, vitronectin, and thrombospondin 9. At the cellular level, the most important 
mediators of hemostasis are fibrin, platelets, and blood vessels 5. 
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 Inflammatory Immediately after formation of clot, inflammation starts. Components of 
the coagulation cascade, inflammatory pathways and immune system are needed to  
prevent ongoing blood and fluid losses, to remove dead and devitalized (dying) tissues and to 
prevent infection 10. Inflammation can be divided into early and late phases depending on the 
time and duration of response and the type of inflammatory cell involve. Early inflammatory 
phase (days 1–2): inflammation begins with the activation of the classical and alternative 
pathways of the complement cascade 11. This leads to infiltration of the wound with neutrophil 
granulocytes (polymorphonuclear leukocytes) that are attracted to the wound site within 24–
48 hours of injury by a number of chemoattractants 12. Late inflammatory phase (days 2–3): 
on arriving at the wound site, blood monocytes undergo a phenotypic change to become 
tissue macrophages 13. Macrophages are thought to be crucial for coordinating later events in 
the response to injury, but the importance of neutrophils and macrophages in wound repair is 
incompletely understood 6. Recent data suggest, however, that a deficiency in either cell type 
can be compensated for by the redundancy in the inflammatory response 14. 
 Proliferative phase The third stage of wound repair — the proliferative phase with  
formation of a new tissue — splits into other four phases: granulation tissue formation and 
fibroplasia, angiogenesis, epithelialization and contraction 6. Proliferative phase starts at about 
day 3 and lasts for 2–4 weeks after wounding and is characterized by fibroblast migration, 
deposition of the extracellular matrix and formation of granulation tissue 15,16. With progression 
of the proliferative phase, the provisional fibrin/fibronectin matrix is replaced by the newly 
formed granulation tissue. Epithelialization of the wound represents the final stage of the 
proliferative phase 12. Approximately 4 days after injury, fibroblasts are attracted to the wound 
by a number of factors, including platelet-derived growth factor and transforming growth 
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factor-β 12, in this conditions they migrate, proliferate and produce the matrix proteins: 
fibronectin, hyaluronic acid, collagen and proteoglycans 5,17–19. Migration induces generation of 
a rudimentary tissue witch takes name granulation tissue. It appears in the wound already 
during the inflammatory phase and continues growing until the wound bed is covered 6. The 
granulation tissue consists of new blood vessels, inflammatory cells, fibroblasts, 
myofibroblasts, endothelial cells and the component of a new provisional matrix 12. This 
provisional ECM is different in composition from normal ECM and its components originate 
from fibroblasts. Such components include fibronectin, collagen, glycosaminoglycans, elastin, 
glycoproteins and proteoglycans. In details, fibronectin and hyaluronan are the main 
components witch create a really hydrated matrix and facilitate cell migration 9 20,21. This 
provisional matrix is then replaced with an ECM more closely resembles to non-injured tissue. 
This morphologic change, attributed primarily to the invading capillaries that underlie the 
granular appearance, also represents at the cellular level the arrival of the permanent 
residents of the repaired dermis. Macrophages, fibroblasts, and blood vessels move into the 
wound space at the same time 22. The macrophages provide a continuing source of growth 
factors necessary to stimulate fibroplasia and angiogenesis; the fibroblasts – the most 
important mesenchymal cells involved in wound healing 23 – produce the ECM necessary to 
support cell ingrowth and help reapproximate wound edges through their contractile 
properties; and blood vessels carry oxygen and nutrients necessary to sustain cell metabolism 
24–26 27. During this phase, it observes production of collagen III with a peak at three weeks and 
continues until the later phase of process, in which it is replaced by the stronger type I 
collagen 14. 
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The formation of new blood vessels is necessary to sustain the newly formed granulation 
tissue. Angiogenesis, also called neovascularization, is a complex process by which damaged 
blood vessels are replaced by “sprouts” from intact capillaries in the local vicinity of the 
wound 6. Local changes in the tissue environment, such as, decreased pH, the inadequate 
tissue perfusion secondary to damaged capillaries, increased lactate and  low oxygen tension 
stimulate angiogenesis 5. In addition, several growth factors and cytokines like VEGF, FGF, 
angiopoietin, and TGF, stimulate and regulate angiogenesis 28. Others angiogenesis inductors 
are proteoglycans, MMPs, and the arrangement of the ECM 29 28. Angiogenesis is imperative 
for other stages in wound healing.  
The formation of granulation tissue is an open wound allows the reepithelialization phase to 
take place. Keratinocytes migration can starts within hours after injury and initially, a single 
layer of epidermal cells migrates from the wound edges to form a delicate covering over the 
exposed raw area 5. Once the denuded wound surface has been covered by a monolayer of 
keratinocytes, epidermal migration ceases and a new stratified epidermis with underlying 
basal lamina is re-established from the margins of the wound inward 19. The migration of 
keratinocytes preferably takes place over an intact basement membrane. More commonly, 
however, wounds breach the basement membrane and keratinocytes must migrate across the 
provisional matrix of collagens I and V, fibronectin, vitronectin, and tenascin 5. Fibrin not only 
serves in a supportive or guidance role but also stimulates keratinocyte migration directly by 
disrupting cellular adhesions and indirectly by exposing keratinocytes to plasminogen, a 
stimulator of migration 30. Analogous to the migration of fibroblasts through the provisional 
ECM, keratinocytes also express a number of enzymes that facilitate the degradation of ECM 
and thereby clear a path for the migrating cells 5. 
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Proliferative phase runs out with contraction, a key phase of wound healing process. 
Differentiations of fibroblasts in myofibroblast phenotype - characterized by large bundles of 
actin-contain microfilaments disposed along the cytoplasmic face of the plasma membrane of 
the cells and by cell–cell and cell–matrix linkages 20 – induces beginning of contraction 
(approximately 1 week after injury) witch continues even after the wound is completely 
reepithelialized 14. Interaction between fibroblasts and myofibroblasts produce new 
extracellular matrix, mainly in the form of collagen, which ultimately forms the bulk of the 
mature scar  31 32. 
 Tissue Remodelling When levels of collagen production and degradation equalize, the  
maturation phase of tissue repair starts 22, there is a continuous synthesis and breakdown of 
collagen as the extracellular matrix during this phase. In this phase, type III collagen, witch 
prevails during proliferation, is gradually degraded and the stronger type I collagen is laid 
down in its place 33 34. In normal wound healing, there is a steady state about 21 days after 
wounding. Originally disorganized collagen fibers are rearranged, cross-linked and aligned 
along tension lines 10. The onset of the maturation phase may vary extensively, depending on 
the size of the wound and whether it was initially closed or left open 35, ranging from 
approximately 3 days 33 to 3 weeks 36. The maturation phase can last for a year or longer, 
similarly depending on wound type 6. 
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Fig. 1: Phases of repair in acute wound healing 
2.1.2 Engineered wound healing models 
Wounds represent a significant and increasing burden on healthcare systems globally and 
new therapies and wound management approaches are urgently required. Numerous 
difficulties are associated to use of small animal models 37, for this reason in vitro wound 
models using human cells in two- and three-dimensional (2D and 3D) 38–42 environments have 
been developed to delineate the molecular mechanisms of cellular repair. Typical examples of 
2D in vitro models involve use of a scratch assay, in which a confluent cell-monolayer is 
scratched with a tool such as a pipette cone or a razor blade, so as to mechanically remove a 
‘‘strip of cells’’ from the monolayer 43. This method is based on the observation that, upon 
creation of a new artificial gap, or ‘‘scratch’’, the cells on the edge of the newly created gap 
will move toward the opening to close the ‘‘scratch’’ until new cell–cell contacts are 
established again 44 38. These in vitro scratch assays allow possibility to evaluate regulation of 
cell migration by cell interaction and cell contraction. Recently have been demonstrated that, 
for cells adhering to their substrate, and despite the presence of a contractile peripheral 
actomyosin cable at the free edge, the final stages of closure of wounds larger than a typical 
cell size result mostly from protrusive lamellipodial activity at the border. In that case, the 
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function of the actin cable appears to be primarily to prevent the onset of migration fingers led 
by leader cells at the free edge 45. Thus by using 2D in vitro scratch assay, mechanical basis 
such as measure cellular forces during epithelial gap closure was been studied. These studies 
revealed one class of closure that involves covering a bare surface in which leading cells in an 
advancing epithelial monolayer migrate across the surface in an adhesion-dependent manner 
39. Across non-adhesive gaps, epithelial cells employ a different mechanism by generating 
traction forces parallel to the wound margin through the contraction of a multicellular actin 
purse string to close the wound 46. Despite these mechanisms explain many aspects of 
reepithelialization, it is unclear how these findings relate to repair of fibrous tissues wherein 
mesenchymal cells ensconced in a fibrillar matrix restore the the 3D architecture of the tissue. 
Skin equivalents have already been developed to investigate in vitro wound healing. Although 
these studies extensively described the re-epithelialization process 42, and the state of 
keratinocyte’s differentiation during healing, to the best of our knowledge a few of information 
on dermal healing and on cell-matrix interaction are reported in literature 47 4849. In order to 
provide a model more closely resembles the in vivo system, here we introduce a 3D 
organotypic construct to study the fibroblasts behavior and to describe the dermal wound 
healing process and the related ECM response. In this perspective, a new 3D human dermal 
equivalent (3D-HDE) 50 – based on endogenous ECM – was used as wound model. Dermal 
full-thickness injury was tested on wound platform testing by two different experimental set 
up. We demonstrate the relationship between cell migration, differentiation marker and ECM 
production during the wound healing process and self-repair capability in our 3D wound 
dermal platform. 
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2.2 Fabrication 3D dermal equivalent model: materials and methods 
2.2.1  Porous scaffold fabrication 
Microporous scaffolds were made by gelatin type B (Sigma Aldrich Chemical Company, 
Bloom 225, Mw=l 76654 Dalton) and it resulted by microporous microbeads with a diameter 
of 50-200 mm.  Microbeads (GPMs) have been prepared according to a modified double 
emulsion technique (O/W/O) [13]. Gelatin was dissolved into 10 ml of water containing 
TWEEN 85 (6% w/v) (Sigma Aldrich Chemical Company). The solution was kept at 60° C. 
Toluene containing SPAN 85 (3% w/v) (Sigma Aldrich Chemical Company) was continuously 
added to the aqueous gelatin solution (8 % w/v) to obtain primary oil in water emulsion. The 
added toluene formed droplets in the gelatin solution until saturation. Beads of gelatin 
containing droplets of toluene were produced through the addition of excess   toluene (30 ml). 
The overload of toluene allowed the obtaining of a double emulsion (O/W/O). After cooling 
below 5° C, 20 ml of ethanol was added to extract toluene and stabilize GPMs. The resulting 
microspheres were filtered and washed with acetone and then dried at room temperature. 
Microspheres were separated selectively by using commercial sieves (Sieves IG/3EXP, 
Retsch, Germany). GPMs with 75-150 mm size range were recovered and further processed. 
Microbeads morphology has been examined by means of Scanning Electron Microscopy 
(SEM). Once obtained scaffold, GPMs have been stabilized by means of chemical treatment 
with glyceraldehyde (GAL), in order to make them stable in aqueous environment at body 
temperature. In particular, 3.8% and 4% have been used of the crosslinking agent. Process 
involves the use of acetone/water solution containing the amount of GAL and mixed at 4° C 
for 24 h. The crosslinked microspheres were washed with acetone and then dried at room 
temperature. GPM were sterilized by absolute ethanol sub-immersion for 24 h before use. 
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2.2.2 Cells isolation and culture 
Primary human foreskin fibroblasts were isolated from human breast (45 years old) obtained 
from routine surgical excisions of normal ski as described previously 51. Briefly, the harvested 
tissue was divided into pieces witch were incubated overnight in 1.8 U/ml Dispase in PBS 
(Sigma, St. Louis, MO, USA) at 4˚ C. After dispase digestion, dermal sheets were separated 
from epidermis with forceps. For isolation of human dermal fibroblasts (HDF), dermal piece 
were scraped and put in 30 ml collagenase A solution (ROCHE) at concentration of 2mg/ml 
for 40 minutes at 37° C. After stop the collagenase solution, piece were resuspended in a 
little volume of Eagle’s BSS Minimum Essential Medium supplemented with 10% fetal bovine 
serum, 100 mg/mL L-glutamine, 100 U/ml penicillin/streptomycin, and 0, 1 mM Non 
Essential Amino Acids. Cells were maintained at 37°C in humidified atmosphere containing 
5% CO2. HDF were propagated in monolayer culture onto 150 mm Petri dishes in culture 
medium (Eagle’s BSS Minimum Essential Medium containing 20% fetal bovine serum, 100 
mg/mL L-glutamine, 100 U/mL penicillin/streptomycin, and 0,1 mM Non Essential Amino 
Acids) with a cell population of 3.5 x103 cells cm-2. HDF were maintained at same conditions 
and 5-9 passages cells were used.  
 
2.2.3 Tissue precursor fabrication and human dermis equivalent assembling 
HDF of 7 passage and GPM differently crosslinked have been used to start µ-tissue 
precursor fabrication. GPM were sterilized by absolute ethanol and successively they washed 
in calcium-free and magnesium-free phosphate buffered saline (PBS) in order to completely 
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remove ethanol. PBS was removed and replaced 30 minutes with the culture medium before 
cell seeding. Once GPM acclimatized, HDF were inoculated with scaffold at initial 
concentration of 11 cell/beads. To seed cells into micro-scaffolds, two medium spinner flasks 
were loaded with 13 x 106 HDF and 231 mg of microbeads. The culture suspension was 
stirred intermittently at 30 rpm (5 min stirring and 30 min static incubation) for the first 6h 
post-inoculation for cell adhesion, and then continuously agitated at 30 rpm. The growth 
medium was replenished on the first day and every 2 days until the end of experiments (7 
days in total). From the day 2th 50 µg/ml of ascorbic acid was added. HD µTP samples were 
taken for assay at day 1, 3 and 6. 
 
2.2.4 Tissue assembling and biohybrid fabrication 
To obtain a single and compact macro-tissue of the desired shape and thickness, the µTP 
suspension was withdrawn from the spinner flask and transferred and cultured in an 
assembling chamber (Fig. 1B). The assembling chamber has a sandwich-like structure (Fig. 
1Ba), in the middle of which is a silicon mould with four empty spaces (1 mm in thickness, 
dimensions 6x12 mm, Fig. 1Bb), where the µTPs assembly takes place. The silicon mould is 
delimited on both the top and bottom sides by two stainless steel rigid grids (Fig. 1Bc) 
characterized by a porous mesh (18 lm) that is able to retain the µTPs. Two 
polytetrafluoroethylene (PTFE) rings (Fig. 1Bd) are placed on the grids on both sides of the 
system and are fastened to each other by means of stainless steel screws, which close the 
system and ensure that the µTPs are retained. The system is autoclavable in each part. The 
µTP suspension was transferred from the spinner flask to a 50 ml Falcon centrifuge tube and, 
after settling, transferred by pipetting into the empty spaces of the silicon mould of the 
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assembling chamber (Fig. 1B) to allow the assembly. Each opening was filled with 
approximately 13 mg of the µTPs. Furthermore, the assembling chamber was placed on the 
bottom of a spinner flask (Bellco biotechnology code 1967- 00050) and completely 
surrounded by culture medium. The spinner was operated at 60 rpm and the medium was 
exchanged every 2 days. After 2 weeks of culture the assembling chamber was opened and 
the biohybrids were collected and used as wound healing platform.  
 
 
2.3 First experimental set-up 
2.3.1  Materials and Methods 
3D-Wound healing model: full-thickness damage  
Maturation chambers were opened and organotypic dermis constructs were transferred into 
petri dish. One type of wound was randomly made using a stainless-steel sterile scalpel 
(Brown No. 11; Feather Safety Razor, Osaka, Japan) in the middle of tissue. Different tissues 
were used in order to study healing process at different time. Each incision was 1 mm in 
length and was performed to the surface of a silicon layer to apply the correct pressure and 
obtain a full-thickness injury. Damaged 3D-HDE was clamped and overlain with an o-ring 
and a silicon layer and was placed in a petri-dish. Manufactured wound tissues were carried 
out in static conditions, at 37° C, 5% CO2 and humidity 90%. Medium and ascorbic acid 
were replenished every 2 days. The wound healing process and its effects were evaluated in 
time-lapse for 20 days. 
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Time-Lapse analysis and wound remodelling 
The wound healing assay carried out on a microscope that combines automated image 
capture, point visiting and incubation, so that multi-position measurements can be carried out 
over time under the same conditions (Olympus IX 50 op). Time-Lapse microscope were: 
equipped with image acquisition software and a scientific-grade digital CoolSnap camera 
(Photometrics), environmental chamber, motorized stage (PRIOR) for multi-position 
acquisition, and motorized focus with autofocus capability to minimize focal drift over time 52. 
An automated system relies on software for triggering image acquisition using a digital 
camera at regular time intervals of 30 min over 24-hour period were used. Moreover, the 
environmental chamber replicates an incubator on the microscope by controlling temperature, 
pH and humidity 5340; it allows samples to remain on the microscope rather than being 
repeatedly taken in and out of an incubator, thus avoiding any compromises in cell physiology 
arising from fluctuations in these parameters. A 10x objective using a standard CCD camera 
was used. 
 
Cellular response 
Morphological analyses were performed on histological section at 14, 17 and 20 days after 
damage. All tissues were fixed in 4% paraformaldehyde for 30 min followed by overnight 
incubation in 2 M sucrose for cryopreserved sections. Samples were embedded in Tissue Tek 
(Killik, Bio Optica, Milano, Italy), submerged in liquid nitrogen vapors for 1 min and then 
stored at -80 °C.  After embedding in OCT, 7-mm sections were prepared from across the 
middle of each wound, by using Criomicrotome (Leica CM 1850, Milano, Italy).  Tissue 
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samples were consecutively cut until the wound was microscopically visible. The dermis 
healing process was monitored after wound. Monitoring was carried out by analyzing data 
from the full extension of the wound in different days post-wounding. Tissue morphology and 
self-repair tissue capability were assessed by performing histological analysis on transverse 
sections of biohybrid, along the peace of the sheet thickness. Samples were stained using 
Hematoxylin-Eosin (HE) (Bio Optica) solutions for frozen section, following standard 
procedure and analysed by an optical microscope (BX53; Olympus Tokyo, Japan).  
For immunofluorescence same slices were used for the anti-Alpha smooth muscle detection. 
The cut was oriented so as to view the cross section of the samples in order to visualize cut 
section. Frozen thick slices were immunostained with specific antibodies for 3 hours followed 
by incubation with the appropriate secondary antibody. The primary monoclonal antibodies 
used in this work is anti-Alpha smooth muscle actin monoclonal antibody blue (diluted 1:100, 
Abcam, Cambridge, UK). The secondary antibodies used were: Alexa Fluor (Life Techologies, 
Milano, Italy) 594 goat anti-mouse with dilution of 1:500 in PBS/BSA 3%. Nucleus detections 
were assessed by using Sytox Green staining (Invitrogen, Life). Markers expression were 
evaluated at 14, 17 and 20 days after damage. 
 
Extracellular matrix response 
To better characterize the increased matrix in the wounded tissue, further targets for selective 
histochemical localization of components of the extracellular ground substance were 
evaluated. These were stained by histochemical reaction, either as an overall reaction 
covering all proteoglycans and glycoproteins. Although the base reaction (PAS reaction) alone 
couples the chromogen to all GAGs and glycoproteins more or less extensively, a combination 
69 
 
of this staining with the Alcian Blue stain, allow a distinction between acidic (Alcian Blue-
positive) and neutral/alkaline (PAS-positive) proteoglycans and GAGs. The Alcian Blue stain 
reacts strongly blue, and the PAS reaction provides a pink stain. The combination of the 
Alcian Blue and the PA stain (Bio Optica) were used as a means of distinguishing neutral 
mucins from acid mucins. 7 µm of frozen sections were stained with the standard Alcian Blue 
(pH 2.5) method followed by the PAS technique.  
Microscopy studies, on our damage human equivalent dermis, were performed on a versatile 
confocal microscopy Confocal Leica TCS SP5 II combined with a Multiphoton Microscope 
where the NIR femtosecond laser beam was derived from a tunable compact mode locked 
titanium: sapphire laser (Chamaleon Compact OPOVis, Coherent). The samples for nonlinear 
imaging were prepared by freezing them and by cutting them in a compact routine cryostat. 
Two-photon excited fluorescence was used to induce Second-harmonic generation (SHG) 
and obtain high-resolution images of unstained collagen structures around and into edge of 
the wound during 20 days of healing. SHG imaging can help reveal interactions between cells 
and ECM answer. Samples were observed by using λex = 840 nm (two photons) and 
λem=415-425 nm. The SHG images, with a size of 200 x 200 µm, were acquired with a 
resolution of 12 bit, 1024 x 1024 pixels by using a 20X N.A. 1.25 objective.  
 
 
2.3.2 Results and Discussions 
Wound healing assays performed on a scaffold-free dermis equivalents model, realized by a 
bottom-up approach 50. A cell-free gap can be created in 3D tissue by direct manipulation.  
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To examine the response of these microtissues to damage, we wounded them in the centre of 
the tissue with a scalpel and then observed how they evolved (Fig. 2a). Scalpels have been 
frequently used because their simplicity of applicability, accuracy and minimal damage to the 
surrounding tissue 54. Nevertheless, because of cutting is created manually, it was difficult to 
generate reproducible wounds for all samples and experiments. It was important to angle the 
scalpel correctly as well as to apply consistent pressure to create a consistent gap 55: applying 
too much pressure we could have damaging the extracellular matrix of tissue, which can 
affect migration rates 53 56. Consequently, to improve wound assay and apply the correct 
pressure, a silicon layer putted under tissue into a petri dish.  
 
 
 
Fig. 2: Wounding and experimental set-up of 3D macrotissues. (a) 3-D dermis equivalent with o-ring in a Petri-dish; (b) 
silicone layer, o-ring, 3-D dermis equivalent in a Petri-dish.  
 
 
Studies on migration of fibroblasts in 3D models largely depend on histological analysis, 
making it impossible to follow migration in real time. For this reason, to examine the response 
of these macrotissues to damage, we wounded 3D engineered constructs in the centre of the 
tissue with a sterile scalpel. Samples were mounted in a perfusion chamber and then 
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observed to evaluate damage closure (Fig. 3a). The open gap created by this “wound” was 
inspected microscopically over time as the cells move in and fill the damaged area by using 
transmitted-light techniques 57. The wound healing assay were carried out on a microscope 
that combines automated image acquisition software and a scientific-grade digital camera, 
environmental chamber, motorized stage for multi-position acquisition, and motorized focus 
with autofocus capability to minimize focal drift over time 53. The environmental chamber 
replicated an incubator on the microscope by controlling temperature, pH and humidity 53. 
Process followed in time-lapse for 17 days and the exposure to the cell-free area induces the 
cells to migrate into the gap. We observed that within a few days after the full-thickness 
incision was made, the gap further widened (Fig. 3a, day 5). As the area of the gap stabilized 
over ten days (Fig. 3c), the rough wound edge smoothened to form an ellipse (Fig. 3a, day 
14), a process associated with alignment and elongation of the cells along the circumferential 
boundary of the wound edge (Fig. 3b). Over the course of the next three days, the gap 
progressively closed, while maintaining its elliptical shape and keeping the centroid position of 
the wound stationary. From literature we know that in the presence of the extracellular matrix 
(ECM), cell crawling with lamellipodia protrusion 43,58,59 seems to be the predominant 
mechanism used to close the voided area, particularly when the gap is a large one as 
happened at 10 days after cut (Fig 3a,). Owing to the stochastic nature of lamellipodia 
formation, this closure mechanism is characterized by a ‘rough’ edge 60 61, as well as wounded 
3D- HDE appears at 10 days after cutting (Fig. 3a). Often it has been observed that one cell 
takes the lead and drags the neighbouring cells along 59. Moreover recently have been 
demonstrated that for cells adhering to their substrate, and despite the presence of a 
contractile peripheral actomyosin cable at the free edge, the final stages of closure of wounds 
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larger than a typical cell size result mostly from protrusive lamellipodial activity at the border. 
In that case, the function of the actin cable appears to be primarily to prevent the onset of 
migration fingers led by leader cells at the free edge 45. Supracellular coordination of this 
motion induces the shape of the gap to become rounder and with ‘smooth’ edges as in this 
platform as well as happened in our organotypic model at 14 days 62 58 63. This mechanism 
has been observed to be involved in closure of small gaps (Fig. 3a, day 14). As reveals figure 
3c, measurements by planimetry of the surface area of the wound reveals that for the first 11 
days, the surface area of wound wasn’t really diminished. When wound surface achieve the 
shape of the gap to become rounder and have ‘smooth’ edges, we found that collective 
migration of cells in a wound model experiment was increased. Really, closure of gaps started 
immediately after the rounder-shape formation (Fig. 3b) and the area of the gap decreased in 
a near-linear manner irrespective of the initial shape (Fig. 3c).  
 
 
Fig. 3: Wounding and closure of 3D macrotissues. (a) Temporal sequence of wound area showing opening and smoothing of 
the wound edge (original magnification- 20 and scale bar, 100 µm). (b) Smoothing of the wound edge and cellular migration 
at 14 days after damage (original magnification- 20 and scale bar, 100 µm). (c) Visual representation of spatiotemporal 
dynamics of gap area during closure, graph showing gap area in function of time.  
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To detect possible differences, tissues were analyzed by histological staining and the 
complete repair verified. In the panel reported in figure 4, histological images of HE (Fig. 4a, b, 
c, d) concerning human dermis equivalent at three times of healing have been shown. 10 days 
after cut, HE staining revealed a partial remodeling of wound edge (Fig. 4a, 4b) as time-lapse 
analysis revealed. 17 days after cut, stains revealed a total closure of tissue in different 
sections: fibroblasts had completely closed the gap (Fig. 4c, 4d). It is possible to note that the 
fibroblasts are completely immersed in collagen matrix and the elongated nuclear morphology 
underlines the good condition of the cells in their own extracellular matrix. There was a weak 
HE staining (Fig. 4c) into new tissue suggesting that percentage neo extra-cellular matrix is 
really low. The biggest part of new tissue formed mostly by cells. It appears a different matrix 
concentration in wound area.  It is interesting to highlight that in 20 days of healing the tissue 
is completely made-up of endogenous ECM. Stains revealed a total repair of tissue in 
different sections and along tissue edge (Fig. 4d). There was a uniform staining in all tissue 
suggesting that extra-cellular matrix completely re-established.  
 
 
Fig .4: Hematoxylin and eosin staining and temporal sequence of micrographs showing closure progressive of wounded 
dermis after: (a) 10 days of healing low magnification (scale bar 200 µm); (b) 10 days of healing (scale bar 100 µm) ; (c) 17 
days of healing (scale bar 100 µm); (d) 20 days of healing (scale bar 100 µm). 
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To better define cellular response and demonstrate the relationship between cell migration 
and differentiation during the wound healing process, we demonstrated that fibroblasts 
become activated and acquire a smooth muscle cell-like phenotype by evaluating levels 
expression of the smooth muscle specific protein α-smooth muscle actin (α-SMA) at 10, 17 
and 20 days after cut. Myofibroblasts are mesenchymal cells, differentiated by fibroblasts, 
with features of both fibroblasts – like spindle shape, prominent cytoplasmic projections, 
abundant rough endoplasmic reticulum – and smooth muscle cells – like longitudinal 
cytoplasmic bundles of microfilaments and multiple nuclear membrane folds 24 64. 
Myofibroblasts have been observed in practically all fibrotic conditions involving retraction and 
reorganisation of extra-cellular matrix and have been the subject of several reviews 65 66. In 
addition to their involvement in skin wound healing 64. The role of myofibroblasts has been 
extensively studied during this process and works confirm their role in the granulation tissue 
formation and wound contraction 66 67. Indeed, after 10 days by cutting, while time lapse 
analysis demonstrated starting of contraction and migration, at same times, 
immunofluorescence analysis detected high levels of SMA (Fig. 5, stain red): studies 
quantifying myofibroblasts in granulation tissue have shown that the number of 
myofibroblasts is proportional to the rate of wound contraction and surface remodelling 6624.  
When healing and repair process progresses in our dermal platform, myofibroblasts begin to 
appear (Fig. 5a, red) and a gradually increase (fig. 5b). At 20 days after cut, when process is 
exhausted, α-SMA wasn’t anymore detected (fig. 5c) as literature reports.  
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Fig .5 Immunofluorescence and temporal sequence of micrographs showing closure progressive of wounded dermis after: (a) 
10 days of healing low magnification (scale bar 200 µm); (b) 10 days of healing (scale bar 100 µm) ; (c) 17 days of healing 
(scale bar 100 µm); (d) 20 days of healing (scale bar 100 µm). Frozen sections were immunostained for α-SMA and Sytox 
Green as nuclear stain 
 
 
Studies demonstrate that myofibroblastic cells synthesize and deposit the extracellular matrix 
components which will replace the provisional matrix 67. Thus, once demonstrated cellular 
response capability of the system and presence of myofibroblasts in damaged tissue, 
PAS/Alcian blue stain has been investigated to demonstrate synthesis of provisional 
extracellular matrix. The Alcian blue at a pH of 2.5 will stain all acid mucins (mostly 
Hyaluronic acid that stains with Alcian blue at pH 2.5.) deep blue but will not color the neutral 
mucins. The subsequent application of the PAS technique will stain the neutral mucins bright 
magenta. Tissues or cells that contain both neutral and acidic mucins may demonstrate a 
dark blue or purple coloration (Jain et al. 2014). In our study mucin histochemistry was an 
indirect evidence of provisional matrix full of HA as we found that acidic mucins are increased 
(Fig. 6). Indeed, edges of wound at 14 days and neo-formed matrix at 17 days showed strong 
Alcian blue staining intensity and a weak intensity of PAS (Fig. 6a, 6b, colour blue), thus 
highlighting the fact that acidic mucins were predominant in these variants – HA is the 
predominant GAG found in loose connective tissues 68. Conversely, the ECM, 20 days after 
cutting, was strongly PAS positive with an increased amount of neutral mucin (Fig. 6c, colour 
magenta).  The presence of this glycosaminoglycan in developing systems has been related to 
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cellular migration; its removal by hyaluronidase marks the onset of differentiation 68. It is 
possible that a hyaluronic acid-rich environment promotes the migration of fibroblasts into the 
wound.  
 
 
Fig .Pas/Alcian Blue stain and temporal sequence of micrographs showing closure progressive of wounded dermis after: (a) 
10 days of healing low magnification (scale bar 200 µm); (b) 10 days of healing (scale bar 100 µm) ; (c) 17 days of healing 
(scale bar 100 µm); (d) 20 days of healing (scale bar 100 µm).  
 
 
The last part of repair process is collagen production and remodelling. In order to demonstrate 
tissue capability to synthetize new collagen in neo-formed matrix we used second harmonic 
generation (SHG) analysis 69. The structure of collagen fibrils was observed by MPM that 
allowed visualize unstained collagen structure. In this purpose SHG imaging was performed 
into the gap in order to highlight collagen timing production in wound edge. The figure 7a, 7b 
and 7c reported the SHG images of 14, 17 e 20 days after cutting respectively, the signal was 
strong only in last image: 20 days after wounding, a relevant quantity of collagen was 
detected into gap (Fig. 7c). After migrating into wounds, fibroblasts commence the synthesis 
of extracellular matrix, cells in the wound undergo apoptosis and the provisional extracellular 
matrix is gradually replaced with a collagenous matrix as in-vivo process 6. 
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Fig .7 SHG and temporal sequence of micrographs showing closure progressive of wounded dermis after: (a) 10 days of 
healing; (b) 17 days of healing; (c) 20 days of healing. Frozen sections were immunostained for αcollagen detection, scale 
bar 100 µm. 
 
 
Christopher Chen (2015), in contrast to mechanisms previously described by planar in vitro 
models to evaluate gap closure, have already demonstrated that fibroblasts close the open 
gap through the coordinated action of force-dependent contraction of the whole tissue, 
circumferential cell migration around the wound edge and assembly of fibronectin scaffolding 
47. With this study they start understand the relevant role of stroma to correctly evaluate cells 
migration, matrix contraction and ECM remodelling (by the expression of fibronectin). 
Following the same path, we investigated the role of stroma during wound healing process 
evaluating tissue contraction and closure, fibroblasts migration and differentiation, 
proteoglycans and endogenous collagen production. Summarize we demonstrated that this 
3D model lead to the possibility of studying in vitro some phases of wound-healing process 
about the effects of variations in human dermis of full- thickness dermal wounds, also we 
demonstrated the relationship between cell migration, differentiation marker and ECM 
production during the wound healing process. 
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2.4 Second experimental set-up 
2.4.1 Materials and Methods 
3D-Wound healing model: cut and assembleMaturation chambers were opened after four 
weeks of maturation and organotypic dermis constructs were transferred into petri dish. 
Porous gelatin microbeads at 3.8% of crosslink were used to obtain a scaffold-free model. 
Using a sterile scalpel (Brown 11), linear full thickness cuts have been made through each 
sample, simulating surgical wounds. 3D-HDE were separated in two parts and washed with 5 
ml of the growth medium. Each parts of tissue were transferred into the empty spaces of the 
silicon mould of the assembling chamber by a shovel, in order to allow contact between the 
two separated edge and to induced healing process. This method it was carried out in order 
to mimic suture effect and process. Maturation chamber were also used as healing chamber. 
Manufactured wound tissues were carried out in dynamic conditions, operated at 60 rpm at 
37° C, 5% CO2 and humidity 90%. Medium and ascorbic acid were replenished every 2 days. 
Repair process and its effects were evaluated at 1 and 2 weeks of healing.  
3D-Wound healing model: morphological analysisMorphological analyzes were performed on 
histological section at 1 and 2 weeks after cut to evaluate microbeads degradation and repair 
process. Hematoxylin-Eosin (HE) (Bio Optica) Masson Trichrome (Bio Optica)  and PAS-
Alcian Blue (Bio Optica) stain were performed.  
 
2.4.2 Results and discussions 
Microscopic analysis and histological stain suggest 3D-HDE wasn’t repaired at 1 week of 
healing (Fig. 8a), at 2 weeks tissue were repaired (Fig. 8b).  
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Fig. 8: Representative images of 3D dermis equivalent (a) soon after cut and (b) after healing. 
 
 
In the panel reported in figure 9, histological images of HE (Fig. 9a), Masson Trichrome (Fig. 
9b) and PAS-Alcian Blue concerning human dermis equivalent at two weeks after wounding 
have been shown. Stains revealed a complete closure of tissue in different sections: 
fibroblasts had completely covered wound area (Fig. 9) except to external border of repaired 
tissue. It is possible to note that the fibroblasts are completely immersed in collagen matrix 
and the elongated nuclear morphology underlines the physiological condition of the cells in 
their own extracellular matrix. There was an intense color both for HE (Fig. 9a) than Masson 
Trichrome staining (Fig. 9b) along new tissue suggesting relevant celluarization of tissue. Fig. 
9c showed strong Alcian blue staining intensity and a weak intensity of PAS (colour blue), 
thus highlighting the fact that acidic mucins were predominant in these variants. 
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Fig .9: Hematoxylin and eosin staining and temporal sequence of micrographs showing closure progressive of wounded 
dermis after: (a) 1 weeks after cut; (b) 2 weeks after cut ; (c) 3 weeks after cut; (d). Scale bar 50 µm 
 
 
Major problem of this platform is the impaired healing. During wound studies by using first 
experimental set-up, tissue repaired after 14 days too but gap was even more pronounced. 
We had suggested a shorter healing time by using this platform and we ascribe this delay to a 
strong tissue contraction for the duration of the culture. We observed a very high variation of 
3D-tissue measurements (Fig. 10). At beginning we obtained a 3D-HDE with measurement 
6x12 mm (Fig. 10a, 10b), immediately after cut 3D-tissue were significantly reduced (Fig. 
10c). 2 weeks after cut (4 weeks of maturation in total) 3D-wounded tissue was even more 
contracted and smaller than 2 weeks of maturation (Fig. 10d). In fig. 10e-10f were reported 
measurements after 4 weeks of maturation (2 weeks after cut).  
 
81 
 
 
Fig .10: Representative panel to show tissue contraction. (a) and (b) measurements of initial mould, (c) and (d) macroscopic 
aspect of 3D dermis equivalent after 2 weeks of maturation and before cut,(e) and (f) measurements of dermis equivalent 
after 4 weeks of maturation (2 weeks after cut). 
 
 
We calculated the change in measures and observed a very high degree of spontaneous 
contractions in 3D-HDE after 2 weeks of maturation (Fig. 11). Except for thickness, length 
and width decreased significantly (Fig. 11a). Measurements variations were strictly function of 
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percentage of contraction. After 2 weeks of maturation 3D-tissue lost about 40% of their 
length and 50% of their widht, after 2 weeks of healing (4 weeks of maturation) about 72% 
and 82% respectively (Fig. 11b). 
 
 
Fig .11: Quantitative analysis of tissue dimension variations (a) in terms of change in measures in nm, (b) in terms of 
contraction. 
 
 
Recent studies demonstrated that cell behaviour can be quite diverse in response to a 
scaffold. Features such as surface chemistry, morphology and mechanics, can have an 
influence over cell fate 70. Recent studies revealed that scaffold stiffness had elicit changes in 
focal adhesion structure, cytoskeleton assembly, morphology, migration and spreading of 
fibroblasts71, and smooth-muscle cells 71. Scaffold properties also affect cell growth, 
differentiation, and organization during tissue repair 3 . We hypnotize scaffold-influence in 
tissue repair at 1 week of healing specially. Imparato et al. 72 have investigated the role of 
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micro-scaffold mechanical properties and degradation rate on the composition, organization 
and maturation of de novo synthesized ECM in the 3D human dermal equivalent tissue used 
by wound model in this work. Their results indicate clearly that composition, organization and 
maturation of de novo synthesized ECM can be controlled by microscaffold properties. Indeed, 
the morphology of HD-µTPs was affected by the GPM’s crosslinking density: 3% HD-mTPs 
exhibited a strong contraction due to the low mechanical properties of the 3% GPM compared 
to cell traction forces. The result biohybrid underwent consistent contraction of both shape 
and thickness even before 2 weeks of culture. Indeed presence of compliant and rapid 
degradable GPM does not support the process of production-degradation and maturation of 
collagen within the scaffold frame.  During a repair process this turnover is even more 
pronounced, migration of myofibroblasts is really important for cell invasion and spreading of 
fibroblasts is necessary for formation of new tissue in wound edge. Thus, the scaffold itself 
should be sufficiently stable to allow new granulation tissue to mature, while the injured 
tissue is replaced by new collagen deposition. Second, the collagen matrix should not persist 
indefinitely, but be degradable within the time limits compatible with the healing process as 
well as is verified by Masci et al. 73. For this reason, the strong contraction of tissue sample – 
before and after cut –doesn’t promote repair but adversely affects wound healing, moreover 
strong contraction detaches the two wounded edges and prevents physical contact. 
2.5 Conclusions 
Wound healing is a dynamic, interactive process that passes in three phases and overlap in 
time: inflammation, tissue formation, and tissue remodelling. Studies, analyzing wound 
healing, use mainly mechanical methods for wound induction, which are laborious and 
difficult to standardize 14. Hereby, we were able to set multiple standardized injuries with 
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defined dimensions in a human full-thickness 3D dermal equivalent, enabling the 
investigation of wound healing. In summary, the model proposed, due to its endogenous 
nature, could represent a valuable tool to study tissue status in vitro at both a cellular and an 
extra-cellular level. Our study paves the way to the development of a new class of in vitro 
wound-tissue models that correctly reproduce in composition and organization the 
extracellular space. Such models would lead to the possibility of studying in vitro some phases 
of wound-healing process about the effects of variations in human dermis of full- thickness 
dermal wounds, including fibroblast proliferation, migration, differentiation and proteoglycans 
expression. In conclusion with our 3D-HDE in vitro model we can demonstrate the 
relationship between cell migration, differentiation marker and ECM production during the 
wound healing process. We believe that our 3D-HDE wound model could be a starting point 
for a novel platform to test dermal wound therapies and could be further improved.  Indeed, 
first experimental set-up allows possibility to evaluate how this 3D-HDE react to a physical 
damage and defines healing in-vitro timing and relate marker to follow. Only problem of this 
platform is reproducibility. Without standardization of experimental variables, it is difficult to 
make meaningful comparisons among different reports in the literature. Furthermore, to 
achieve a high level of accuracy and reproducibility, a well-defined procedure for the wound 
healing assay is crucial. Developing a standard approach for the wound healing assay 
promotes comparability between studies and could lead to a useful database containing 
collective migration data for a variety of cell lines. In this perspective, second experimental 
set-up work out this question. Anyway contraction phenomenon is a strong question to 
considerate: scaffold – and relate tissue – contraction, also affect tissue repair process by 
inhibiting or altering healing. We conclude that the in vitro model presented here is a good 
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approximation of the complex and dynamic composition and organization of the ECM in a 
human cutaneous wound and is potentially useful for studying biology of wound healing. This 
wound platform could provide as starting point to investigate the efficacy of potential anti-
wound healing drugs. Significant future developments will include the continued development 
of artificial human dermal equivalent products under consensus efficacy standards and that 
uses cells embedded into an endogenous ECM without contraction phenomenon and that 
better recapitulate in vivo healing-timing. Summarize this bioengineered 3D model of wound 
closure may become a valuable tool to investigate the underlying mechanics of gap closure 
and ECM remodelling. 
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3 Engineered 3D human dermis model to study the scar 
formation: recapitulating cellular and extracellular 
machineries during dermal repair.  
3.1 Introduction  
Tissue-engineered human skin equivalents (HSEs) have contributed significantly to the 
understanding of biological processes and skin diseases 1 2 3. Wound healing has been 
studied before in HSEs in which wounds were created by burning, freezing, or punching the 
epithelium 4 5 : however to the best of our knowledge a few of information on dermal healing 
are reported in literature. Indeed, the central question debated in the literature in skin wound 
healing are often process and mechanism of the creation and extension of the epidermal 
tongue 6 5–8. Dermal substitutes function as an optimized wound bed to support outgrowth of 
keratinocytes from the wound margins, or from an epidermal component such as a skin graft, 
cultured skin or an artificial epidermal component containing autologous or allogeneic 
keratinocytes 9–11. Following any injury,various intracellular and intercellular pathways must be 
activated and coordinated if tissue integrity need to be restored. Relevant processes regards 
dermal matrix 12. In dermal wound healing, after a skin injury, several interacting events are 
initiated including inflammation, tissue formation, angiogenesis, tissue contraction and tissue 
remodeling 13. Regarding the phase of tissue formation and contraction (third phase of wound 
healing process), the crosstalking between cells and extracellular matrix (ECM) is crucial. 
After the blood clot has formed, white blood cells invade the wound region by migrating 
through the ECM 14. Fibroblasts subsequently differentiate into myofibroblasts and migrate 
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into the region and begin to replace the blood clot with provisional matrix 15,16. The formation 
of this provisional matrix – granulation tissue – and regulation of collagen fibers and bundles 
formation by the fibroblasts, as well as the organization of these elements into an endogenous 
stroma after wounding, was the key issue of these two stages 17 18.  
Regarding the last phase of a wound repair – remodeling – recent studies confirmed that the 
natural evolution of an adult wound healing process is scar formation. Scarring can be 
assessed clinically by using the Vancouver scar scale, or the Manchester scar proforma or the 
Visual Analogue Scale 19. Scarring involves high collagen deposition in response to tissue 
injury, for this reason a variety of treatment modalities have been attempted. Moreover, with 
the introduction of new treatments for in vivo injury, as the development of skin replacement 
materials and grafting with autologous split thickness grafts, scar question is more and more 
relevant. In spite of dermal substitutes are important in treating full thickness skin defects, 
relevant problems associated to their use because usually severe scarring occurred after 
grafting 10,20,21. For this reason in the last few years there was an increase of focusing on the 
mechanism of scar formation and progression. It is really important to in vivo track the wound 
status at the molecular, cellular and tissue levels, helping to understand the scarring response 
mechanisms and prevent it. Recent works have shown that molecular biology at the wound 
margin is important for scarring 22, and the advancing or receding of a wound margin may be 
potentially used for prevention 14. Although several of the ECM–fibroblast interactions have 
been experimentally studied, this area remains poorly understood 23,24 25. This is partly 
because all interactions have not been found, but mainly because the processes involved 
interact in a complex manner. A major limitation in the progress of scar management is the 
lack of physiologically relevant human models to explore the pathogenesis of scar formation 
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and to test new therapeutics 26 10. Today, human models, animal models, and in vitro cell 
culture models are used to study skin scar formation. The possibilities to use patient as in 
vivo models are limited, due to obvious ethical considerations 27. Current and common 
alternative is the use of animal models 28. Despite the large number of studies describing 
mice, pigs, rabbits, rats and other animals as models to investigate scar and hypertrophic 
scarring, the wound healing process in these species presents significant differences and is 
extremely difficult compared with human tissue specially because of lack of specific 
biomarkers, differences in skin structure and physiology with consequently differences in scar 
formation, presence of aberrant scars formation 29 30 31. Moreover, with increasing pressure 
from the EU (Directive 2010/63/EU) for the replacement, reduction, and refinement of the 
use of animal models, there is an urgent need to develop a physiologically relevant and 
responsive in vitro human wound model to investigate the matrix response and the 
pathogenesis of scar formation  32–34 26. In current in vitro models, is possible to study only cell 
migration, contraction and proliferation, cell–cell interaction and protein synthesis 35 28 26. 
Accurate study it is not possible to evaluate granulation tissue and scar formation. Moreover it 
was seen that an in vitro model of burn wound healing in human skin did not induce the 
differentiation of myofibroblasts 36 10. This shows that a human skin equivalent model – with 
just a stratified and differentiated epithelium – isn’t enough to correctly mimic in vivo situation. 
To date, no gold standard exists for the treatment of scar tissue. 
In this perspective, the development of biologically relevant three-dimensional human dermal 
equivalent (3D-HDE) as in vitro model can emerge as new challenge in tissue engineering to 
evaluate dermal remodeling during healing process. The fabrication of an endogenous stroma 
that interact in a complex manner with cells population allows possibility to confirm the 
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relationship between cell migration, differentiation marker and ECM production during a 
wound healing process and also demonstrated the same in vivo timing into a highly 
responsive endogenous matrix. Also, the presence of a responsive dermis – that mimic in vivo 
response occurred during a repair that take place in the stroma – allows possibility to evaluate 
scar formation and to study and understand processes involved during scarring. This should 
be a great achievement considering difficulties to understand mechanism of scarring and the 
high request of new strategies for prevention. 
 
3.2 Materials and methods 
3.2.1 Tissue precursor fabrication and human dermis equivalent production 
The 3D-HDE was prepared as reported by Palmiero et al. (2010). Briefly dermal microtissues 
were produced by seeding HDF passage seventh on biodegradable gelatin porous 
microcarries. Glyceraldehydes has been used as gelatin crosslinker at 4% w/w of the 
microbeads, only this percentage has been used in order to obtain a completely endogenous 
tissue without the presence of microbeads or contraction phenomenon. The microbeads / 
fibroblasts cultures were propagated in two spinner flasks for 7 days using a continuous 
stirring regime 9. Each spinner flask was initially loaded with 6.5 x 106 HDF and 115 mg/ml of 
microbeads, corresponding to 11 cells/beads. From the day 2th, 50 µgr/ml of ascorbic acid 
were added. After 7 days, microtissues precursor transferred into maturation chamber in order 
to provide the assembly of microtissues and the fabrication of macrotissue by using a bottom 
up approach as previously described (Imparato et al. 2013). Maturation chamber was used to 
allow their molding in parallelepiped-shaped and obtained the 3D-HDE (thickness 1 mm, 
99 
 
dimensions 6x12 mm). Maturation of 3D-HDE was carried out in dynamic conditions by 
placing the chamber on the bottom of a spinner flask operated at 60 rpm at 37°C, 5% CO2 
and humidity 90%. Maturation process was carried out for 4 weeks in order to provide a 
scaffold-free dermis construct. The medium was changed every 2 days and ascorbic acid was 
added at each medium change at a concentration of 50 µgr/ ml.  
 
3.2.2 3D-Wound healing model 
Maturation chambers were opened and organotypic dermis constructs were transferred into 
petri dish. Using a sterile scalpel (Brown 11), linear full thickness cuts have been made 
through each sample, simulating surgical wounds. HDE were separated in two parts and 
washed with 5 ml of the growth medium.  
Critical step: it is important to cut in the middle of the tissue in order to obtain two similar 
dermis layers and minimize any possible variation caused by the difference of tissue 
dimension.  
Each parts of tissue were transferred into the empty spaces of the silicon mould of the 
assembling chamber by a shovel, in order to allow contact between the two separated edge 
and to induced healing process. This method is based on the observation that, upon creation 
of a new artificial gap in our tissue, the cells on the edge of the newly created gap will move 
toward the opening to repair damage until new tissue-tissue contacts are established again.  
Assembling chamber is similar at the maturation chamber used to realize dermis. 
Manufactured wound tissues were carried out in dynamic conditions, operated at 60 rpm at 
37° C, 5% CO2 and humidity 90%. Medium and ascorbic acid were replenished every 2 days. 
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The wound healing process and its effects were evaluated 1, 2 and 3 weeks after damage for 
all samples. The final 3D disk-shape wound- tissues were named as follows: cut 1 week after 
wounding, cut 2 weeks after wounding and cut 3 weeks after wounding respectively (with 
related controls). 
 
3.2.3  Histological and immunofluorescence analysis to monitor wound healing 
process 
Morphological analyzes were performed on histological section at 1, 2 and 3 weeks after 
damage. All tissues were fixed in 4% paraformaldehyde for 30 min followed by overnight 
incubation in 2 M sucrose for cryopreserved sections. Samples were embedded in Tissue Tek 
(Killik, Bio Optica, Milano, Italy), submerged in liquid nitrogen vapors for 1 min and then 
stored at -80 °C. Samples were cut in slices 7 µm in thickness by using Criomicrotome 
(Leica CM 1850, Milano, Italy).  The dermis healing process was monitored after wound. 
Monitoring was carried out by analyzing data from the full extension of the wound in different 
days post-wounding. ECM composition and tissue morphology were assessed by performing 
histological analysis on transverse sections of biohybrid, along the peace of the sheet 
thickness. Samples were stained using Hematoxylin-Eosin (H&E) and Masson’s Trichrome 
(Bio Optica) solutions for frozen section, following standard procedure and analyzed by an 
optical microscope (BX53; Olympus Tokyo, Japan).  Also, immunofluorescence staining were 
carried out, for this analysis wounded sample were oriented so as to view the cross section of 
the samples in order to visualize cut section. For immunofluorescences analyses, frozen thick 
slices were immunostained with specific antibodies for 3 hours followed by incubation with 
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the appropriate secondary antibody. The primary monoclonal antibodies used in this work 
include:  
• anti-Alpha smooth muscle actin monoclonal antibody blue (diluted 1:100, Abcam, 
Cambridge,UK)  
• anti-Hyaluronic acid polyclonal antibody red (diluted 1:50, Abcam).  
The secondary antibodies used were: Alexa fluor (Life Techologies, Milano, Italy) 594 goat 
anti-mouse and 546 Rabbit Anti-Sheep IgG H&L (Abcam) respectively. Antibody monoclonal 
was produced in mouse and the polyclonal antibody was produced in rabbit, all secondary 
antibodies were diluted 1:500 in PBS/BSA 3%. Nucleus detections were assessed by using 
Sytox Green staining (Invitrogen, Life Technologies, Italy). The samples were investigated by 
using confocal microscopy (TCS SP5 II Leica, Milano, Italy).  Hyaluronic acid production and 
alpha-smooth muscle actin expression were evaluated at 1, 2 and 3 weeks after damage. 
 
3.2.4 Second harmonic generation (SHG) analysis 
Microscopy studies, on our damage human equivalent dermis, were performed on a versatile 
confocal microscopy Confocal Leica TCS SP5 II combined with a Multiphoton Microscope 
where the NIR femtosecond laser beam was derived from a tunable compact mode locked 
titanium: sapphire laser (Chamaleon Compact OPOVis, Coherent). Our control were foreskin 
at 30 and 80' years old 37. The samples for nonlinear imaging were prepared by freezing them 
and by cutting them in a compact routine cryostat. Before imaging, samples were unfrozen 
and closed with a microscope coverslide together with some PBS droplets in order to 
maintain the natural tissue osmolarity. Two-photon excited fluorescence was used to induce 
Second-harmonic generation (SHG) and obtain high-resolution images of unstained collagen 
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structures around edge of the wound during three weeks of healing. SHG imaging can help 
reveal interactions between cells and ECM answer. Samples were observed by using λex = 
840 nm (two photons) and λem=415-425 nm. The SHG images, with a size of 200 x 200 µm, 
were acquired with a resolution of 12 bit, 1024 x 1024 pixel by using a 20X N.A. 1.25 
objective. Collagen production in wound area was evaluated at 1, 2 and 3 weeks after 
damage. 
 
3.2.5 Scanning electron microscopy (SEM) analysis 
To quantitatively assess the collagen-related changes from 1 to 3 weeks of healing, we 
characterized the morphologies of the collagen fibers by a scanning electron microscopy 
(SEM, FEG_Ultrapluss by ZEISS).  Previously, to preserve sample morphology, a critical point 
drying (CPD-300 Leica) was used for drying samples slices 7 µm thick. Samples were then 
mounted on aluminum stubs and coated with 100 A ultrathin platinum layer (thickness 7 nm) 
in a glow-discharge coater to minimize charging and increase the conductivity of the biological 
material (sputter coater Cressington_HR 208). All data shown were taken on an 
environmental SEM with a field-emission electron gun at electron energy of 4.00 keV by using 
Inlens detector for high magnification and ESB detector for low magnification. The microscopy 
studies and fiber tracking were then performed on combining image acquisition by SEM and 
the ImageJ: we evaluated bundles diameter of each fiber extracted by ImageJ analysis 
software Image J®. Twenty images were evaluated for each time and related control, all 
images were acquired with same parameters and same magnification. 
Furthermore, the microscopy studies and fiber tracking were then performed on combining 
image acquisition by SEM and the CT-FIRE algorithm.  Fibers are then extracted using an 
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automated tracking algorithm called fiber extraction (FIRE). We evaluated diameter, length, 
angle and position of the automatically extracted fibers with those of manually extracted fibers 
in twenty-five SEM images of control and damaged matrix. We found that the curvelet-
denoising filter followed by FIRE, a process we call CT-FIRE, was successfully applied to track 
collagen fiber shape changes over time. CT-FIRE is an automated tracking method that can 
extract the geometric structure of 3-D collagen images and is capable of generating 
information about the number, length, and curvature of the collagen fibers in an image. The 
first step of this method is to apply a threshold to form a binary image such that foreground 
pixels represent potential fibers and background pixels represent pixels where no fiber is 
present. Next, the distance transform on the binary image is performed to yield the distance 
from each fore-ground pixel to the nearest background pixel. Then, the maximal ridges of the 
smoothed image formed by the distance transform are searched to create a list of nucleation 
points. Branches are formed by extending the fiber from each nucleation point based on fiber 
trajectory. Short fiber branches are then pruned and closely associated fibers are finally linked 
based on the fiber length, fiber direction, and the distance between adjacent fibers. In the 
associated FIRE software 38, there are about 20 adjustable parameters initialized with default 
values. There are usually only a few parameters that need to be adjusted such as those 
impacting the binary image generation, the search for nucleation points, and fiber linkage. To 
our knowledge, the FIRE method has only been tested on confocal reflectance and confocal 
fluorescence images of in vitro collagen gels, but has not been applied to extract collagen 
fibers from SHG images of tissue. Each preprocessing technique described in this article was 
followed by nearly identical implementations of the FIRE algorithm. The only difference is in 
the threshold used for creating the initial binary image. This threshold was hand optimized to 
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produce the highest quality fiber extractions across all test cases for each algorithm 39. To 
evaluate algorithm accuracy and compare tissues exposed to a physical damage or not, 
unwounded HDE matrix, at same maturation timing for each wounded HDE matrix, were used 
as control 
 
3.2.6 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM - Tecnai G220_FEI Company) was performed to 
observe collagen bundles in the HDE three weeks after wounding. Orhanotypic tissue was 
first fixed with 2.5% glutaraldehyde (SigmaAldrich) in sodium cacodylate buffer 0.1 M (pH 
7.2), washed with sodium cacodylate buffer and then fixed with 1% aqueous osmium tetroxide 
(Electron microscopy sciences, USA). Afterwards, the samples were dehydrated in a graded 
series of ethanol (SigmaAldrich), block contrasted with 1% uranyl acetate (Merck, Germany) 
and embedded in EMbed 812 (Electron microscopy sciences, USA). The prepared ultrathin 
sections (80 nm) were contrasted with 0.3% lead citrate (Merck, Germany) and imaged with a 
2HS_EAGLE transmission electron microscope camera at an accelerating voltage of 120 kV 
and a time exp of 1 sec_ 2048 x 2048.  
 
3.2.7 Stat Image analysis and statistics. 
Images were analyzed with the in-house CT-FIRE software and ImageJ. Data analysis, 
statistics, graph plotting and fitting were performed using the MS Excel (Microsoft) and 
Kaleidagraph (GraphPad) software. Statistical analysis was performed by an ANOVA-Tukey 
HSD test. The significance threshold was set for the Tukey HSD test as pvaleau < 0.001. For all 
data sets, experiments were repeated in independent.  
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3.3 Results  
3.3.1 Macroscopic view 
In this study, a bottom-up approach was exploited to build up 3D tissue constructs in vitro: 
microtissues precursor were growth for 7 days and assembling and maturation process was 
carried out for four weeks. It was obtained a scaffold-free dermis equivalents perfectly 
modeling (Fig. 1a). As show in figure 1a human dermis equivalent appears ductile, flexible, 
strong and resistant to torsion stress and at the pull. 
Once realized 3D-HDE constructs, wound healing studies are performed on dermis’s 
endogenous matrix. Understanding how dermis and extra-cellular matrix are orchestrated in 
our full-thickness wound healing models requires the development of injury assays. In this 
purpose, a cut-induced directional wound healing assay systematically and quantitatively 
reproducible was used. Linear full thickness cuts have been made through each sample, 
simulating surgical wounds and separating HDE in two parts (Fig. 1b). Each parts of tissue 
were transferred into the empty spaces of the silicon mould of the assembling chamber (Fig. 
1c), flaps are overlapped (Fig. 1d, 1e).  
Tissues results repaired after 1 week (Fig. 2a). Macroscopic analysis confirmed this result at 
2 and 3 weeks too (fig 2b, 2c). Indeed figure 2 reported the multichannel macroscopic images 
of 1 week after injury (Fig. 2a), 2 weeks after injury (Fig. 2b) and 3 weeks after injury (Fig. 
2c). Still at 1 week tissue appeared repaired but edges aren’t completely overlapped and 
tissue is not tight (look at the edge of tissue in Fig. 2a). Samples at 2 and 3 weeks results 
completely repaired and edge of tissues fused each other.  
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Fig. 1: Dermis equivalent fabrication and wounding and closure of 3D macrotissues. (a) 4% biohybrid at 4 weeks of culture. 
(b) Macrographs of macrotissues after damage. (c) Temporal sequence of wound maturation chamber. (d) Flaps 
approximation to mimic suture closure. (e) Final wound arrangement. Scale bar, 6mm 
 
 
 
Fig. 2: Macrographs of macrotissues after 1 week of wounding (a); after 2 weeks of wounding (b); after 3 weeks of wounding 
(c). Original magnification 10X and scale bar, 200µm). 
 
 
3.3.2 Morphological evaluation of wound closure 
To detect possible differences between samples at different healing times, tissues were 
analyzed by histological staining and the complete repair verified. We chose the 3-week time 
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point, after the initial wound. In the panel reported in figure 3, histological images of 
Hematoxylin-Eosin (Fig. 3a, c, e) and Masson’s Trichrome (Fig.b, d, f) concerning human 
dermis equivalent at three times of healing  have been shown. At 1 week of healing, 
Hematoxylin-Eosin and Masson’s Trichrome stain revealed a partial closure of tissue in 
different sections. Fibroblasts had covered wound area partially (Fig.3a, 3b), there wasn’t 
staining in the core tissue (Fig. 3a arrow), suggesting that only external flaps repaired and 
cells were not infiltrated in the tissue. At 2 weeks of healing stains revealed a complete 
closure of tissue in different sections: fibroblasts had completely covered wound area (Fig. 3c, 
3d). It is possible to note that the fibroblasts are completely immersed in collagen matrix and 
the elongated nuclear morphology underlines the physiological condition of the cells in their 
own extracellular matrix 40. There was an intense Hematoxylin-Eosin staining (Fig. 3c) and a 
weak Masson’s Trichrome stain (Fig. 3d) along new tissue suggesting a poor synthesis of 
new ECM compared to cellular number and accordingly, a poor omogeneity of extra-cellular 
matrix to the pre-existing matrix. It is interesting to highlight that after 3 weeks of healing the 
tissue is completely made-up of endogenous ECM. Stains revealed a total repair of tissue in 
different sections and along tissue edge (Fig. 3e, 3f). There was a uniform staining in all 
tissue suggesting that extra-cellular matrix completely re-established.  
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Fig .3: Hematoxylin and eosin staining and temporal sequence of micrographs showing closure progressive of wounded 
dermis: (a) showing alignment of cells at the wound edge and partial wound closure after 1 week of healing; (b) revealing 
total wound closure after 2 weeks of healing; (c) revealing the presence of a neo-ECM in neo-formed tissue after 3 weeks of 
healing. Original magnification-20X and 40X and scale bar, 100 and 50 µm. 
 
 
3.3.3 The 3D wound model recapitulates cellular and extra-cellular matrix 
pathophysiological process occurring during wound healing in vivo 
After injury, in-vivo wound healing follows a series of tightly regulated, sequential events, one 
of these is granulation tissue formation.  Granulation tissue matrix is rich in fibronectin and 
hyaluronic acid and fibroblasts differentiated 14. To demonstrate granulation tissue synthesis 
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in our 3D-HDE wound model, we evaluated Hyaluronic acid and fibronectin up-regulation and 
fibroblasts differentiation. In particular in images 4 and images 6 is shown HA (red) and 
fibronectin (red) signals respectively. Moreover presence of myofibroblasts were confirmed by 
staining for α-SMA in fig. 2 (blue), network of  neo-collagen were exploiting by multiphoton 
microscopy with Second Harmonic Generation (SHG) analysis. 
 HA expression.  
After injury, in-vivo wound healing follows a series of tightly regulated, sequential events, one 
of these is granulation tissue formation.  Granulation tissue matrix is rich in fibronectin and 
hyaluronic acid. HA is a glycosaminoglycan usually content in skin at basal levels but it is 
further elevated transiently in granulation tissue during the wound healing process 17. To 
demonstrate typical presence of proteoglycans in our platform and its capability to generate 
granulation tissue during a repair process, we evaluated hyaluronic acid production in the 
neo-forming and undamaged matrix 1, 2, and 3 weeks after wounding. Levels of HA are 
detectable both in wound area than in area away from physical damage (Fig.4). At beginning 
of process, levels of HA increase in the wound area (stain in red) (Fig. 4a, 4b) and 
quantitative analysis – by using ImageJ - demonstrate high statistically significant between cut 
and control (pvalue < 0.001 by performing an ANOVA-Tukey HSD test.) (Fig. 5, box). With the 
culture time, this difference was even more pronounced and quantitative analysis 
demonstrated a low and continuous production of HA in undamaged matrix (Fig. 4d) and a 
peak in wound area (Fig. 5, box). The level of proteoglycan was significantly increased at 2 
weeks after injury compared to levels at 1 week. This difference was detected again 
compared at 2 and 3 weeks after wounding: the two values are statistically highly different 
with a p<0.001 by performing an ANOVA-Tukey HSD test (Fig. 5, box).  At the end of process, 
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HA levels were present (Fig. 4d, e) but decreased significantly and there aren’t statistically 
different between cut and control (Fig. 5, box). 
 
 
 
Fig.4: immunofluorescence analysis of: (a) wounded area of dermis equivalent 1 week after wounding; (b) unwounded area 
of dermis model (CTRL) 1 week after wounding; (c) wounded area of dermis equivalent 2 weeks after wounding; (d) 
unwounded area of dermis model (CTRL) 2 weeks after wounding; (e) wounded area of dermis equivalent 3 weeks after 
wounding; (f) unwounded area of dermis model (CTRL) 3 weeks after wounding. Frozen sections were immunostained for 
Hyaluronic acid and Sytox Green as nuclear stain. Scale bar, 50µm. 
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Fig.5: Hyaluronic acid production expressed in pixel/nuclei in neo-formed tissues and undamaged tissues at 1, 2 and 3 
weeks of healing. Control represents the corresponding undamaged tissue of dermis equivalent. p < 0,05. All bars are 50 µm. 
 
 
 Fibronectin expression.  
To better define nature of granulation tissue in our organotypic model, we evaluated 
fibronectin (FN) production in the neo-forming matrix and in area away from physical damage 
1, 2, and 3 weeks after wounding too (Fig.6 ). Fibronectin, a predominant type of provisional 
matrix protein, directs wound fibroblast migration into the fibrin clot 14. Levels of FN are 
detectable both in wound area than in area away from physical damage. Low levels of FN are 
detectable in all time in undamaged matrix (Fig.6b, d, f). In the center of control the intensity 
of fibronectin signal is almost absent, but it is easily detected on the edge, this suggests that 
where the dermis is anchored on the grid the cells are able to produce more fibronectin and 
also the network of these proteins is more similar to native dermis. At beginning of process, 
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levels of FN increase in the wound area (stain in red) (Fig. 6a, 6b) and quantitative analysis – 
by using ImageJ - demonstrate high statistically significant between cut and control (pvalue < 
0.001 by performing an ANOVA-Tukey HSD test.)(Fig. 7, box). With progressing time, this 
difference was even more pronounced and quantitative analysis demonstrated a high and 
continuous production of FN in undamaged matrix (Fig. 6d) (Fig. 7, box). The level of 
fibronectin was increased at 2 weeks after injury compared to levels at 1 week. This 
difference was even more pronounced at 3 weeks after wounding. In the end of process, FN 
levels were detected (Fig. 4d, e) and increased significantly (Fig. 7, box).  
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Fig.6: immunofluorescence analysis of: (a) wounded area of dermis equivalent 1 week after wounding; (b) unwounded area 
of dermis model (CTRL) 1 week after wounding; (c) wounded area of dermis equivalent 2 weeks after wounding; (d) 
unwounded area of dermis model (CTRL) 2 weeks after wounding; (e) wounded area of dermis equivalent 3 weeks after 
wounding; (f) unwounded area of dermis model (CTRL) 3 weeks after wounding. Frozen sections were immunostained for 
Fibronectin and Sytox Green as nuclear stain. Scale bar, 50µm. 
 
 
 
Fig.7: Fibronectin production expressed in pixel/nuclei in neo-formed tissues and undamaged tissues at 1, 2 and 3 weeks of 
healing. Control represents the corresponding undamaged tissue of dermis equivalent. p < 0,05. All bars are 50 µm. 
 
 
 α-SMA expression.  
In a tissue damaged, fibroblasts are activated and migrate in the wound area where they 
differentiate into α-smooth muscle actin (α-SMA)-expressing myofibroblasts. Fibroblasts 
undergo a series of phenotypic changes during granulation tissue formation and assume 
some characteristics of smooth muscle cells to become actin- rich myofibroblasts. The 
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appearance of myofibroblasts corresponds to the start of collagen-rich granulation tissue 
contraction 14. In this purpose, to understand cellular reply to a physical damage in 
organotypic dermis construct and better demonstrate granulation tissue formation, we also 
analyzed fibroblasts answer (alpha-Smooth muscle actin expression) in the neo-forming and 
undamaged matrix 1, 2, and 3 weeks after wounding (Fig.8). 1 week after wounding, cells in 
the wound area showed an initial production of α-SMA (stain in blue) (Fig.8a). In figure is 
reported marker expression both in wound area than in area away from physical damage (Fig. 
8a, b). α-SMA expressed only in wound area, values are next to zero in undamaged matrix 
(Fig.8b, d, f). There is high statistical significance between cut and control with a pvalue < 0.001 
by performing an ANOVA-Tukey HSD test (Fig. 9, box). With progressing time (2 weeks after 
cut), this difference was even more pronounced compared at 2 weeks after injury: the 
expression of differentiation marker advanced always only in wound area.  Figures 8 relieve 
the strongest signal at this time. αSMA expression was transient and it was almost no 
detectable when healing process is exhausted(Fig. 9, box). Figures relieve a transient 
expression of signal. 
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Fig.8: immunofluorescence analysis of: (a) wounded area of dermis equivalent 1 week after wounding; (b) unwounded area 
of dermis model (CTRL) 1 week after wounding; (c) wounded area of dermis equivalent 2 weeks after wounding; (d) 
unwounded area of dermis model (CTRL) 2 weeks after wounding; (e) wounded area of dermis equivalent 3 weeks after 
wounding; (f) unwounded area of dermis model (CTRL) 3 weeks after wounding. Frozen sections were immunostained for  
α-SMA and Sytox Green as nuclear stain. Scale bar, 50µm. 
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Fig.9: α-SMA production expressed in pixel/nuclei in neo-formed tissues and undamaged tissues at 1, 2 and 3 weeks of 
healing. Control represents the corresponding undamaged tissue of dermis equivalent. p < 0,05. All bars are 50 µm. 
 
 
 SHG analysis.  
The structure of collagen fibrils was observed by MPM that allowed visualize unstained 
collagen structure by exploiting SHG. SHG analysis was exploited to investigate the tissue 
capability to secrete new collagen, in this perspective SHG analysis and α-SMA (Fig. 10 d, e, 
f) signals were combined. In this purpose SHG imaging was performed on neo-forming ECM 
in order to highlight collagen timing production in wound edge. At the beginning of the 
process fibroblasts differentiate into myofibroblasts and migrate into the empty space 
between the two edges of primary stroma using the primary stroma as a scaffold for their 
migration (Fig. 10a, 10d). By the 14th day myofibroblasts stopped to migrate, reaching the final 
number (Fig. 10b) and in the wound edge it is possible to observe an initial SHG signal that 
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displays a less dense and organized matrix compared to mature stroma of undamaged control 
(control is part of the 3D-HDE, far from the wound).  In details, at time 1 week, collagen in 
wound area wasn’t detected (Fig.10d). The signal of collagen is detected only at 2 weeks after 
wounding in wound area, by using SHG analysis (Fig. 10e). At this time, wound area is fully of 
differentiated cells (Fig.10b) and low immature collagen (Fig.10e). Indeed intensity of signal is 
different between neo-forming ECM and mature stroma of undamaged control at this time: in 
pre-formed ECM it is possible to distinguish presence of mature collagen while in neo-
forming ECM it is possible to distinguish fibrils of the collagen but they are not still completely 
organized. At 3 weeks after wounding, once contribute to connective tissue remodeling by 
exerting traction forces, myofibroblasts regressed and disappeared by apoptosis (Fig. 10c) on 
wound 41; the two matrices are comparable and there are not differences between the wound-
area matrix and the pre-formed matrix of tissue (Fig. 10e).  
At least, number cells per Area in neo-formed tissue and in pre-existing tissue at two and 
three weeks after wounding were estimated (Fig. 10 h, 10i) by using ImageJ software.  
Results obtained at two weeks are statistically no different (Fig. 11). Unsurprisingly, statistical 
analysis showed a significant difference between results obtained in cut and control at three 
weeks after wounding. Numbers cells per Area weren’t estimated at 1 week: tissue is not fully 
repaired. 
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Fig.10: immunofluorescence of α-SMA analysis and second harmonic generation (SHG) of: (a) wounded area of dermis 
equivalent 1 week after wounding; (b) wounded area of dermis model 2 weeks after wounding; (c) wounded area of dermis 
equivalent 3 weeks after wounding. Second harmonic generation (SHG) of: (d) wounded area of dermis equivalent 1 week 
after wounding; (e) wounded area of dermis model 2 weeks after wounding; (f) wounded area of dermis equivalent 3 weeks 
after wounding. Second harmonic generation (SHG) and Sytox Green of: (g) wounded area of dermis equivalent 1 week after 
wounding; (h) wounded area of dermis model 2 weeks after wounding; (i) wounded area of dermis equivalent 3 weeks after 
wounding. Frozen sections were immunostained for collagen detection. Scale bar, 50µm. 
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Fig.11: Number of cells per Area expressed in N°nuclei/µm2 in neo-formed tissues and undamaged tissues at 2 and 3 
weeks of healing. Control represents the corresponding undamaged tissue of dermis equivalent. p < 0,05. All bars are 50 µm. 
 
 
3.3.4 ECM composition and remodelling  
We investigated the 3D architecture of neo-formed matrix to assess the self-repair capability 
of tissue and the remodeling matrix after wounding in our model. We obtained such 
information mainly from scanning electron microscopy (SEM) of the samples ECM close to 
the wound and ECM far from the wound. By means of SEM is possible to obtain important 
morphological information into the three-dimensional (3D) arrangement of stroma structures. 
The morphology, remodeling and distribution of collagen were examined and compared to the 
control at 1, 2 and 3 weeks after wounding. Matrix 0-50 µm away from cut (Fig. 12, red arrow 
and box) were considered as neo-formed matrix and were used for these studies to 
demonstrate stroma answering capability –of our dermal platform – to a physical damage; 
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core organotypic model, ECM more than 500 µm away from cut (Fig. 12, blue arrow and box), 
were considered as pre-formed/undamaged matrix (control).  
 
 
Fig. 12: Scanning electron images at 568 magnification illustrate 3D dermis equivalent and its subdivisions to detect and 
analyze neo-formed matrix (red box) and pre-formed matrix (blue box) for quantitative analyses. Scale bars, 20 µm. 
 
 
Parameters were defined in which the x directions were parallel to cut imaging into tissue 
slices, y directions were perpendicular to cut imaging into tissue slices aligned and the z 
direction was vertical (perpendicular to the imaging plane in the circumferential direction) and 
corresponding to thickness of 3D model (Fig. 13).  
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Fig. 13: Scanning electron images at 761 magnification illustrate division wounded dermis equivalent added in a Cartesian 
system. X-axis is the cut direction. All images for CT-Fire and ImageJ elaboration were taken with this cut direction and 
considering this as x-axis. Scale bars, 20 µm. 
 
 
SEM data revealed two different levels of stromal organization: collagen fibrils and fibril 
bundles (Fig. 13). Indeed, at contrary of SHG analysis, collagen in wound area was already 
detected at time 1 week after wounding by SEM analysis (Fig. 14a, arrow): images detected a 
fully cellularised neo-matrix with a really low amount of collagen fibrils (first level of stromal 
organization). The collagen fibrils constitute the smallest structure of the collagen organization 
which could be observed by electron microscopy. The transverse and longitudinal sections of 
the damaged tissue show a considerable variation in collagen organization but not in diameter 
of the fibrils during healing time into a neo-formed matrix (Fig. 14a, 14c, 14e) and into an 
increasingly mature matrix (Fig. 14b, 14d, 14f). The diameter of the fibrils of dermal equivalent 
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in neo-formed matrix and pre-formed matrix is found to vary respectively from 15 to 70 nm 
and from 20 to 120 nm. Thus, the most relevant data are not then evolution of single fibrils 
diameter but the matrix reorganization with consequent coalescence of the fibrils into small 
collagen bundles.  
 
 
 
Fig. 14: Scanning electron images illustrate: (a) wounded area of dermis equivalent 1 week after wounding; (b) unwounded 
area of dermis model (CTRL) 1 week after wounding; (c) wounded area of dermis equivalent 2 weeks after wounding; (d) 
unwounded area of dermis model (CTRL) 2 weeks after wounding; (e) wounded area of dermis equivalent 3 weeks after  
Scale bars, 1 µm. 
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To learn more about matrix remodeling we evaluated collagen assembly. We investigated the 
bundles formation in the ECM, using SEM and ImageJ analysis. The results showed that the 
fibrils were organized in big groups, which occurred in extended channels. These groups of 
fibrils are termed ‘collagen bundles’ (Fig. 15). At the beginning the number of bundles is really 
low, within the new stroma at 1 week after wounding, there were very few single collagen 
fibrils in the extracellular space. At two weeks after wounding, matrix assembled and the 
bundles are well defined in wound area (Fig. 15). It is important to note that ECM profiles are 
fibrils in transverse section. It was not possible to count entire fibrils or bundles because 
some are too long to be contained within the SEM volumes we studied. In 3 weeks after 
wounding, collagen bundles are even bigger and even more assembled (Fig. 15). Analysis of 
SEM images demonstrated that diameter collagen bundles increased during development, 
with mean bundles diameter increasing from 141.28 nm ± 22.5 nm at 2 weeks of maturation 
(2 weeks after wounding), to 365.81 ± 94.8 nm at 7 weeks of maturation (undamaged matrix 
3 weeks after wounding) (Fig. 15). Notably, the increase in collagen bundles diameter 
occurred uniformly throughout the ECM and even if was not confined to collagen bundles 
close to wound edge, it is more and more pronounced in neo-formed matrix. Indeed in such 
zone there is high statistical significance between neo-formed and mature matrix with a pvalue 
< 0.001 by performing an ANOVA-Tukey HSD test. With progressing healing-time (3 weeks 
after cut), this difference with mature matrix was less pronounced compared at 2 weeks after 
injury but always present. Furthermore there is high statistical significance between neo-
formed matrix at 2 and 3 weeks after wounding. This simple, key observation is critical to 
understanding how collagen bundles growth in diameter depend upon the distance from the 
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cut. Analysis of the bundles showed a pronounced increase in the bundles formation profiles 
after 2 weeks of healing. After 6 weeks of maturation (mature matrix in undamaged control at 
2 weeks of healing) the ECM assembling reaches a steady-state (Fig. 14, pvalue < 0.001).  
 
 
Fig. 15: Box of the diameter of collagen bundles in undamaged tissue at 1 week of healing and in neo-formed tissues and 
undamaged tissues at 2 and 3 weeks of healing. Control represents the corresponding undamaged tissue of dermis 
equivalent (box blue). p < 0,05. All bars are 1 µm. 
 
 
At least, fibrils collagen distribution was evaluated. The microscopy studies and fiber tracking 
were performed on combining image acquisition by SEM and the CT-FIRE algorithm.  Fibers 
are extracted using an automated tracking algorithm called fiber extraction (FIRE) and angle 
collagen fibers were obtained. Collagen fibers orientation analysis were carried out at 2 and 3 
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weeks and neo-formed and relate mature matrix were compared at each time as reported in 
figures 16 and 17. During the process of assembly, changes in collagen orientation are 
revealed. This analysis compares the empirical fits of four differents matrix – whose values 
close to 0 and 180 indicate a co-alignment with the cut direction and a parallel direction – 
and the normal (gaussian) distribution for fibers distribution changes using chi-square 
goodness-of-fit tests. Interestingly, neo-formed matrix and pre-existing matrix – both at two 
than three weeks after wounding – exhibited significantly different trends (Fig16a - 17a neo-
formed matrix, 16b – 17b pre-existing matrix). The data clearly show that neo-formed 
matrices are normally distributed. Neo-formed matrix distribution at two weeks has a µ = 
45°, σ= 0,014 and a R2 = 0.98 (Fig. 16a), while at three weeks has a µ = 95°, σ= 0,04 
and a R2 = 0.96 (Fig. 17a). Conversely, mature matrix at 2 and 3 weeks after wounding, 
displayed a broader and an indefinite distribution of orientation fibers Consequently, hasn’t 
normally distributed (pvalue > 0.05). Summarizing, high rate of collagen fibrils were oriented at 
45° and at 90° respect to the cut axis in neo-formed matrix 2 and 3 weeks after wounding 
respectively while, undamaged tissue shows more random organization without a preferential 
orientation and an anisotropic structure. 
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Fig. 16: Histogram of neo-formed fibers orientation along cut direction at 2 weeks of healing in (a) neo-formed tissue, (b) in 
pre-existing tissue. Fit with normal distribution. Range orientation angles: 0-180 degree. 
 
Fig. 17: Histogram of neo-formed fibers orientation along cut direction at 3 weeks of healing in (a) neo-formed tissue, (b) in 
pre-existing tissue. Fit with normal distribution. Range orientation angles: 0-180 degree 
 
 
3.3.5 Transmission electron microscopy (TEM) investigations  
TEM investigations were carried-out at three weeks after wounding to confirm collagen 
bundles formation, as well as the organization of these elements into an endogenous stroma 
when healing process is exhausted. TEM investigations confirmed the large amount of big 
collagen bundles in ECM with a maximum of 500 nm in diameter (Fig. 18e) and that the 
collagen bundle, not the collagen fibril, was the principal structure produced by the fibroblast 
and used in the construction of the damaged stroma after three weeks of wounding. 
Moreover a different tissue cellularization is verified when healing process is exhausted (look 
paragraph 4.3.3). As presented in figure a significant difference in cellular number, between 
pre-existing (Fig. 18a, 18b) and neo-formed matrix (Fig. 18c, 18d), was observed. Mature 
matrix consists of a surface full both of cells than ECM where fibril bundles are intimately 
associated and surrounded by fibroblasts (Fig. 18a, 18b). Conversely, neo-formed matrix is 
almost entirely rich of ECM (Fig. 18c, 18d) and poorly of cells. 
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Fig. 18: Transmission electron images illustrate: (a) unwounded area of dermis equivalent 3 weeks after wounding; (b) 
unwounded area of dermis equivalent 3 weeks after wounding with higher magnification; (c) wounded area of dermis model 
3 weeks after wounding; (d) wounded area of dermis equivalent 3 weeks after wounding with higher magnification; (e) 
collagen bundle formation in wounded area of dermis equivalent 3 weeks after. Scale bars, 5 µm for lowest magnification, 1 
µm for higher magnification, 200 nm for collagen bundle image. 
 
 
3.4 Discussions 
The central question debated in the literature in skin wound healing are often 
reepithelialization process and mechanism of the creation and extension of the epidermal 
tongue 6. But cutaneous wound healing also involves processes about dermal matrix as: 
provisional matrix (or granulation tissue) formation, fibroblasts infiltration and differentiation, 
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extracellular matrix (ECM) remodeling and scar formation 4042. Fibroblasts represent the first 
population of mesenchymal stromal cells and play an essential role in regulating normal 
tissue homeostasis and wound repair through their synthesis of extracellular matrix (ECM) 
and their mechanical interactions 43. However, the utility of these cells for wound repair 
therapy and in vitro studies of dermal repair has been limited by difficulties to incorporate 
these cells in a 3D architecture made-up of a responsive stroma, fully composed by 
endogenous ECM and not exogenous scaffold 42. For example, Masci et al. (2016) evaluated 
NIH3T3 fibroblasts migration and proliferation in a type I collagen scaffold extracted by equine 
tendon 44; in other works, it was used iPSC-derived fibroblasts for tissue repair and 
regeneration that exhibited augmented capacity to deposit collagen proteins in 2D monolayer 
culture 45 or it was used deepidermized dermis (DED), Glyaderm or synthetic polymers as 
healing model 3 36 46. Also, it has been seen that an in vitro model of burn wound healing in 
human skin did not induce the differentiation of myofibroblasts 36 10. But, in vitro studies 
involving the dermal healing process are prevented by the fact that currently 3D dermal 
equivalent are based on collagen as exogenous scaffold and by using models that doesn’t 
reproduce in composition and organization the extracellular space. Indeed, one of the first 
problem associate to use of the current in vitro models, is limitation in the progress of scar 
management consequently to the lack of physiologically relevant human models that gives the 
opportunity to explore the pathogenesis of scar formation. 26 10 To derive a consistent theory of 
how the cellular processes of migration, proliferation, and differentiation are intertwined and 
how ECM answers in dermal wound healing, we proposed a novel in vitro tool to facilitate the 
study of cells and ECM in a damaged dermis that are inaccessible in vivo in humans and that 
cannot be performed using the existing in vitro model. Thus, once realized a 3D-HDE 
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constructs by a bottom-up approach 9, endogenous matrix was injured, handled gently and 
tissues accurately approximated in order to mimic a surgical healing 47. In this way 
proliferative and remodeling phase, occurring during wound healing are recapitulated 13. 
Morphologic analysis of H&E and Masson’s Trichrome stained sections (Fig. 3) demonstrates 
tissue is able to repair itself in a short time. It is interesting to highlight that 3D construct is 
completely repaired and made-up of endogenous and homogeneous ECM only after 3 weeks 
of healing, even if wound gap is completely closed after two weeks (Fig. 2 and 3). Thus ECM 
remodeling begins only a few days after injury and lasts for a long period as well as in vivo 
process such as the last stage of wound repair — remodeling phase — begins 2 weeks after 
injury 12. Indeed, at beginning of healing, 3D-construct recapitulate the typical steps of the 
proliferative phase occurring in an human dermis as the increase of hyaluronic acid (HA) and 
fibronectin (FN) levels and the fibroblasts differentiation 14. In this stage, fibroblasts, which are 
attracted from the edge of the wound, are stimulated and some undergo a series of 
phenotypic changes to assume characteristics of smooth muscle cells and differentiate into 
myofibroblasts already from first week, and with a peak of expression at two weeks from 
injury 48. Myofibroblasts are contractile cells that, over time, initialize tissue migration and 
contraction and bring the edges of damaged tissues together. These two cellular population 
interact and produce extracellular provisional matrix, mainly in the form of HA and FN 12.  
Considering that current in vitro model doesn’t correctly study fibroblasts differentiation 
phenomenon and considering that myofibroblasts may represent an important element in the 
pathogenesis of contraction, capability to detect fibroblasts differentiation is an important 
result in an in vitro study 49. In this perspective, it’s important highlight that repair process 
involved in our 3D-HDE wound model, follows a series of tightly regulated, sequential events, 
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as well as in vivo 50 14. At beginning, we observed granulation tissue formation: higher levels of 
FN and HA facilitate cell migration for subsequent collagen production and assembling at two 
and three weeks. In details, we observed a moderate increase of HA and FN at beginning of 
process (HA is synthetized after 4 weeks of in vivo injury and FN, which is poor at resisting 
injury, in vivo provides the main structural support for the wound clot) and an high increase in 
levels of HA and FN at 2 weeks of healing. We also observed transient levels of alpha-SMA 
and myofibroblasts detection only at one and two weeks of healing in the wound area. This is 
a relevant data in the light of the fact, it is well accepted that myofibroblasts appear 
temporarily in granulation tissue during wound healing and are absent in a normal scar 14,49but 
are present permanently in hypertrophic scars 28,51 and other fibrotic settings 49,52. After two 
weeks of healing, this provisional matrix is replaced by the collagen to provide strength to the 
wounded area, the ECM that replaced granulation tissue, is similar but not equivalent to that 
found in normal tissue. These data was confirmed by SEM investigations carried out at two 
and three weeks of healing – by SHG analysis. The presence of new endogenous collagen at 
different timing of α-SMA expression, suggested that cells not only migrated and 
differentiated but also works correctly. To the best of our knowledge, no other 3D-HDE 
recapitulates granulation tissue formation and spontaneously synthetized large amount of 
collagen bundles. Flasza et al, for example, realized a 3D scaffold composed of a provisional 
matrix human fibrin, into which fibroblasts are initially embedded and then, induce collagen 
deposition only by supplementary media with factors such as TGF-β, insulin, ascorbate and 
plasmin 53. Others works used 3D scaffolds supplemented with collagen, glycosaminoglycans 
(GAGs) (hyaluronic acid and proteoglycans), fibronectin, and growth factors 11. Conversely, our 
organotypic construct not only results in the formation of granulation tissue but also allows 
131 
 
possibility to evaluate remodeling phase. Indeed, once granulation tissue is realized and 
healing process is exhausted (at two weeks of healing), α-SMA wasn’t anymore detected 
(Fig. 10), cells in the wound undergo apoptosis, fibroblasts commence the synthesis and 
assembly of extracellular matrix, and the provisional extracellular matrix is gradually replaced 
with a collagenous matrix as literature reports 13. To verify scar formation, we investigated the 
3D architecture of this neo-formed matrix and assess the tissue capability to reestablish and 
remodeling matrix after injury comparing neo-formed tissue with an undamaged tissue. We 
demonstrated that later in wound healing as remodeling occurs, it is possible detected 
formation of collagen bundles. Indeed we observed a complex organization after two weeks of 
healing (consequently two weeks of maturation) and an increase of collagen bundles 
diameter during development. Notably, the increase in collagen bundles diameter occurred 
uniformly throughout the ECM and even if was not confined to collagen bundles close to 
wound edge, it is more and more pronounced in neo-formed matrix. With progressing healing-
time (3 weeks after cut), this difference with mature matrix was less pronounced but always 
present and relevant compared at 2 weeks after injury. This simple, key observation is critical 
to understanding how collagen bundles growth in assembling depend upon the distance from 
the cut. Analysis of the bundles showed a pronounced increase in the bundles formation 
profiles after 2 weeks of healing that continues more and more at three weeks, conversely 
mature matrix of undamaged tissue is in steady-state and it is possible a balance between 
matrix degradation and remodeling. Thus, matrix remodeling starts and keeps going over 
three weeks when healing process is exhausted as well as in vivo happen: the third stage of 
wound repair — remodeling — begins 2 weeks after injury and lasts for weeks or more; 
during this stage, all of the processes activated after injury wind down and cease 12 54. This 
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continuous remodeling is confirmed by analysis of fibers orientation. At an early stage of 
remodeling phase collagen fibers are mostly aligned at 45° to the wound because of tissue 
works to complete healing and fill wound (Fig. 16); conversely at three weeks, collagen fibers 
are mostly aligned perpendicular to the wound. No preferential orientation was detected in 
undamaged matrices but an anisotropic distribution is observed. A random-like structure 
organization and an anisotropic aspect is typical in normal skin and is the first difference 
evaluated between a normal human skin and a scar 55. The most significant difference 
between normal tissue and scar tissue seems to be the orientation of the fibrous matrix 56. A 
cutaneous scar is a macroscopic fibrous disturbance in the normal tissue architecture and 
occurs in the setting of both surgical and traumatic wounds: it is the normal outcome of the 
wound-healing process and occurs after trauma, injury or surgery to any tissue or organ in the 
body 57. Such scars are consequence of a repair mechanism that replaces the missing normal 
tissue with an extracellular matrix consisting predominantly of excessive levels of fibronectin 
and collagen types I and III strongly oriented 58. Scar formation when healing process is 
exhausted was ultimately demonstrated in our 3D-HDE wound model too. To this end, ECM 
deposition and remodeling within both the wound region and healthy peripheral tissue are 
considered. We have already mentioned a preferential distribution of collagen fibers both at 
two and three weeks after wounding in the wound region. From literatures we know that 
human scar have greater collagen density because of less cellularization and more alignment 
than normal tissue, although the alignment is parallel to the skin and consequently 
perpendicular to the cut. This preferential fibers orientation is the most significant difference 
between scar and normal tissue 56 59. Our data suggest that neo-formed tissue after three 
weeks of healing have typical scar features as: poor cellularization, high levels of fibronectin 
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(FN doesn’t results in a transient overexpression as HA), preferentially fibers orientation 
approximately at 90° to the cut. In figure 19 reported representative images of neo-formed 
matrix/scar and pre-existing matrix/normal tissue and recapitulate the central characteristics 
of a scar. Histological differences define scar from normal/undamaged tissue: the normal 
pattern of collagen fiber bundles from lost dermis is replaced with collagen fiber bundles 
arranged in array parallel to the surface and perpendicular to cut. SHG and 
immunofluorescence techniques prove differences in ECM organization and composition 
between the two matrices and detected levels of FN higher in neo-formed matrix than in 
undamaged tissue. SEM and TEM investigations confirm a preferential fibers orientation in a 
scar poor of cells. Thus, the new ECM that replaced granulation tissue when healing is 
exhausted is characterized by a new architecture that differs from the original in fiber 
orientation, fibronectin expression and cellularization: all typical aspects of a normal scar 
occurring during in vivo healing process. The 3D-HDE tissue capabilities to induce fibroblasts 
differentiation and granulation tissue and scar formation are even more relevant at light of the 
last three decades of literatures reported and confirmed that the early gestation fetus has the 
remarkable ability to heal skin wounds without scar. Since that time, research demonstrated 
in general that fetal skin contains more hyaluronic acid than adult skin 57, that the hyaluronic 
acid content of the extracellular matrix is increased more rapidly than in adult wounds 57 and 
that, in embryonic scar-free healing wounds, are present more primitive fibroblasts and 
consequently, lower levels of myofibroblasts than in adult scar-forming wounds 58 14 22. 
Because these differences, several investigators have proposed a role of hyaluronic acid in 
scarless healing and many studies are trying to investigate fibroblasts differentiation process 
60 61 62 but many more studies are needed. We think that our organotypic 3D-model is a good 
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platform to investigate scar formation thanks to their ability to induce fibroblasts 
differentiation, to promote granulation tissue formation – at same in vivo timing – and to 
induce scar formation. 
 
 
Fig. 19: 3D-dermis equivalent 3 weeks after wounding (a) neo-formed tissue, (b) pre-existing tissue. Images of: HE stain, 
Masson’ Trichrome stain, TEM invastigation, immunofluorescence of Fibronectin and Sytox Green, SEM investigation, SHG. 
 
 
3.5 CONCLUSION 
The model proposed, due to its endogenous nature, could represent a valuable tool to study 
tissue status in vitro at both a cellular and an extra-cellular level after a physical damage. Our 
study paves the way to the development of a new class of in vitro tissue models that correctly 
reproduce in composition and organization the extracellular space. Such model would lead to 
the possibility of studying in vitro the effects of variations in human dermis on selected 
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aspects of both cellular and extracellular components. Specifics repair phenomena such as 
formation of granulation tissue and matrix remodeling with scar formation are recapitulated in 
our model at the same in vivo timing. Moreover it has been reported that wound contraction 
and scar formation in an in vivo model could be prevented with a responsive substitute dermal 
matrix seeded with skin cells, but not with unseeded similar matrices 4 but, to date, no gold 
standard exists for the treatment and study of scar tissue. In this perspective, our 3D-HDE 
wound model could be a valid platform to study scar formation mechanism and could be 
possible to use the human dermal equivalent model as novel platform to test dermal wound 
therapies and for the prevention or treatment of dermal scarring.  
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4 Development of engineered 3D human skin equivalent in vitro 
model to study melanoma process 
4.1 Introduction  
4.1.1 In vivo melanoma process 
Melanoma is a type of cancer that develops from the pigment-containing cells known as 
melanocytes 1. This rare form of skin cancer accounts for only 4 % of all skin cancers but it 
causes the greatest number of skin cancer-related deaths worldwide 2 3 . Overall, in the last 
years, the global incidence of melanoma is increasing, with approximately 200,000 new cases 
and 65,000 melanoma-associated deaths each year 3 .The primary cause of death in 
cutaneous melanoma are metastasis 4. The overall survival for patients with metastatic 
melanoma is poor 5 and novel forms of treatment are needed considering that traditional 
chemotherapeutic agents fail 6. For this reason, early detection and diagnosis is necessary 7 
and the evolution of melanocytic lesion morphology remains an important diagnostic tool 1. 
Currently, identification of primary cutaneous malignant melanoma (CMM) is mainly based on 
the famous ABCDE criteria: Asymmetry, Border, Color, Diameter, Evolution 7. These 
classifications allows possibility to distinguish benign lesions, nevi, from melanomas, 
physicians 8 7. After four decades of studies, clinic-pathologic prognostic markers have been 
consistently identified in several studies: age at diagnosis (with worse prognosis in older 
patients) 3, male gender 9, growth phase (radial vs. vertical) 10, Breslow thickness (BT) 11, level 
of invasion 6, presence of ulceration and its extension 11, presence and density of tumor-
infiltrating lymphocytes (TILs) 12, presence of microsatellites 13, presence of vascular and/or 
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lymphatic invasion 14, and the mitotic rate (MR) 7. The most important of these is the Breslow 
index, although it is merely a measure of tumor depth and is a reflection of the changes 
occurring in the growth characteristics of the cells 15. Indeed, melanoma undergoes different 
phases and malignancy degree related to infiltration cells capability. Presence of dysplastic 
nevi means presence of a premalignant lesion with a specific cytology and architecture 16. The 
second step of disease is formation of malignant lesions, in this phase cells grow primarily in 
a horizontal direction, remaining within or near the epidermis; in this so-called radial growth 
phase (RGP) stage, the cells have not yet acquired metastatic capacity and are restricted to 
the epidermis only 16 17–19. Radial growth phase (RGP) melanoma cells proliferate and form 
nests in the epidermis, but do not invade the dermis 19,20. In this phase, cancer cells are 
incapable biologically of generating metastatic events. Radial growth phase comprises 
neoplastic melanocytes growing in a horizontal array as single cells and small nests 
predominantly in an intra-epidermal location. The radial growth phase may also involve the 
papillary dermis 17. As cells begin to grow into the dermis, they enter a histologically defined 
vertical growth phase (VGP) which has been postulated to be the first point at which the 
tumor gains metastatic capacity 21. Conversely to RGP, VGP cells cross the basement 
membrane, invade and proliferate in the dermis 15,21. Subsequent step is metastatic (met) 
melanoma formation that rapidly invades deep into the dermal compartment until arriving into 
organs 22. Migration and dermis invasion are the result of a specific interaction between 
tumoral and stromal cells 23 in which where cells lose their epithelial features including their 
sheet-like architecture and polarity. Cells also develop a mesenchymal phenotype, taking on a 
spindle-like, fusiform morphology, become motile, and start expressing mesenchymal markers 
24 25 like: lumican, glypican, N-cadherin, osteonectin (SPARC), osteopontin, 
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metalloproteinases, integrins 26–32. A relevant phenomena during switch RGP-VGP is the 
switch of cadherins (calcium-dependent molecules which belong part of adherens junctions 
family): loss of E-cadherins with gain of alternate neural isoforms (N-cadherin) 15 33.  
In the last years, a key genetic alteration has been identified in melanoma progression 34–37. In 
each case, the first step is the activation of a single ‘driver’ oncogene subsequently, additional 
genetic alterations occur such as additional driver mutations or heterozygous loss of 
suppressors 38 31. In 40%-60% of melanoma cases, oncogene BRAF is involved and activated 
with specific mutation BRAFV600E 39. This oncogene known to be critical for the proliferation 
and survival of melanoma cells through activation of the RAF/MEK/ERK mitogen activated 
protein kinase pathway (MAPK) 39 40 41. For this reason BRAF is an attractive target for anti-
melanoma therapy 42. In this perspective, several BRAF inhibitors are currently being tested; 
for example, the BRAF inhibitors RAF-265 (Novartis), PLX4032 (Plexxikon/Roche), and 
GSK2118436 (GSK) are in advanced stages of clinical trials (ClinicalTrials.gov). Encouraging 
results from a clinical trial with the BRAF inhibitor PLX4032 were recently reported 43 44 43, 
however, most patients who initially responded to treatment with PLX4032 relapsed, 
suggesting that chronic treatment with BRAF inhibitors is associated with development of 
drug resistance 39 38. Thus, other studies and researches are the key to destroy this disease. 
 
4.1.2 Engineered melanoma models 
Cutaneous malignant melanomas represent an important clinical problem because of its high 
capacity to metastasize 45. Currently melanoma is still studied in vitro using 2D cell cultures, 
spheroids or co-cultures in 3D microenvironement 46–48. Obviously, conventional 2D cell culture 
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is not representative of the cellular environment: tissue-specific architecture, mechanical and 
biochemical cues as well as cell–cell communication are lost when 2D models were used 49. 
The lack of 3D structure is more and more relevant in case of melanoma studies because the 
first problem of this cancer is precisely invasion and infiltrative capability of cells. Thus, 
microenvironement is fundamental to fabricate valid platform of study and screening. Typical 
human skin reconstructs consist of artificial skin fabricated from isolated cutaneous cell 
populations 50–53. The reconstructs comprise a stratified, terminally differentiated epidermal 
compartment and a dermal compartment consisting of fibroblasts embedded in exogenous 
collagen 54. The co-culture of keratinocytes and melanoma cells induce fabrication of a tumor 
skin and can be used as an alternative to animal testing for studies melanoma invasion 47. 
Tissue culture of melanoma cells also induces a different epidermis structure and phenotype 
depending of grade malignancy of the cell lines used. Different studies compared the 
phenotypes and the behavior of melanoma cells derived from primary and metastatic sites in 
order to study the biological properties of melanoma cells from different stages of progression 
were used 20,5556. Different research groups demonstrated that, in 3D skin model, melanoma 
cells lines displayed characteristics that are consistent with the original tumors from which 
they are derived, such as their motility and invasiveness. For example, cell lines derived from 
RGP primary melanoma are unable to invade the dermis, indeed in RGP melanoma 
reconstructs, fibroblasts and keratinocytes can still form an intact basement membrane 57. 
Conversely, when VGP metastatic melanoma cells were incorporated into skin reconstructs, 
they displayed rapid proliferation and aggressive invasive growth deep into the dermis 58. 
Accordingly, we developed a complex three-dimensional (3D) human skin equivalent model in 
which the organized 3D architecture of the native skin is reproduced. Purpose of our work 
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was analysed a disease that mainly adversely affect epidermis. In this perspective, human 
melanoma cell lines derived from primary sites were added to this 3D engineered skin model. 
4.2 Fabrication and characterization of tumor tissue micromodules 
4.2.1 Materials and methods 
Cell expansion and melanoma-μTP-culture 
A375-1619 (ATCC® CRL-1619™) were sub-cultured onto 150mm2 Petri dishes in culture 
medium (Eagle’s BSS minimum essential medium containing 10% fetal bovine serum, 100 
μg/ml−1 L-glutamine, 100U/ml−1 penicillin/ streptomycin, and 0.1mM nonessential amino 
acids). Cells were maintained at 37 °C in humidified atmosphere containing 5% CO2. A375 
of passages 4–7 were used. Gelatine microbeads having a diameter of 75–150 μm, stabilized 
by 4% of glyceraldehyde were fabricated by means of a modified double emulsion technique 
(O/ W/O) as previously reported [14]. The resulting microspheres were filtered and washed 
with acetone and then dried at room temperature. To make the HD-μTP, spinner flask 
bioreactor (250 ml, CELLSPIN, Integra Bio-sciences) was inoculated with a cell density of 105 
cell ml−1 and a gelatine microbeads density of 2mgml−1 in order to obtain an initial ratio of 10 
cells per microbead. Two separate experiments were carried out. Previously the culture 
suspension was stirred intermittently at 30 rpm (5 min stirring and 30 min static incubation) 
or the first 6 h post-inoculation to allow cell adhesion, and then continuously at 30 rpm for the 
entire duration of the process. Then, the culture suspension was stirred intermittently at 30 
rpm (5 min stirring and 30 min static incubation) for the entire duration of the process. All 
cultures were maintained at 37 °C in a humidified 5% CO2 incubator. The culture medium 
was replenished on the first day and every 2 days until the end of the experiments.  
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A375-μTP proliferation and aggregation  
To evaluate the aggregation capability of the A375-μTP both in continuous than 
discontinuous stirring conditions, aliquots of 1ml containing μTP were collected at each time 
point (days 1, 3, 5, 6, 7, 8 and 10) from the spinner culture and placed under microscope 
(Olympus CK X41). The acquired images were processed by using ImageJ® software. At the 
same times, 3 aliquots of 300 μl each were transferred to a cell culture dish having and the 
number of A375-μTP were counted using a microscope. After that, the suspension was 
placed in a 1.5 ml eppendorf tube, gently washed twice with PBS and then treated with the 
yellow tetrazolium MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) to 
performed cell proliferation assay.  
 
Histological analysis  
At culture day 6, and 9 (discontinuous stirring conditions), aliquots of 1ml were collected from 
the spinner culture and the A375- μTP were stained with N-cadherin (1:100, monoclonal, 
Abcam) and SYTOX® Green (INVITROGEN) for the detection of tumor adherens junctions 
protein and cell nuclei, respectively. The A375- μTP were fixed with 4% paraformaldehyde 
and rinsed twice with PBS buffer. Immunofluorescences were performed on paraffin-
embedded tissue sections with sodium antigen retrieval. Then the samples were stained 
overnight with N-cadherin at 4° C. Alexa-fluor 594 (1:500, Abcam) was used as secondary 
antibody. Then samples were incubated with SYTOX® Green stock solution (10 mg ml−1 in 
dimethyl sulfoxide), diluted in PBS (1/500 v/v) for 10 min at 37 °C. ). Samples were 
investigated by using confocal microscopy (TCS SP5 II Leica, Milano, Italy). 
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4.2.2 Results and discussions 
In this work melanoma microtissues were engineered and used as micromodules to evaluate 
melanoma cells adhesion capability. Cell-scaffold aggregation and N-cadherin expression 
were analysed for the investigation. A375-μTPs were fabricated by culturing melanoma cells 
within gelatine porous microbeads in a dynamic spinner culture [13, 14]. The same methods 
was already used to obtain HDF-μTP, and have previously proved that, under such 
configuration, the interaction arising among fibroblasts and the surface of the gelatin 
microscaffolds induce cell-scaffold aggregation and collagen production 59. A375-μTP 
evolution was evaluated during 10 days of the spinner culture both in continuous than 
discontinuous stirring conditions. Figure 1 reports the time evolution of cells showing if cells 
assembled around microbeads. At day 7 of spinner culture in continuous stirring conditions, 
tumor-μTPs are not assembled (Fig. 1a), conversely the number of cells per A375-μTP 
increased during all 10 days of spinner culture (figure 1B), starting from 10 cells per A375-
μTP up to 200 cells per A375-μTP in discontinuous stirring conditions. Imparato et al. 
(2013) have previously proved that the interaction arising among fibroblasts and the surface 
of the gelatin microscaffolds, triggered mechano-transduction pathways involved in the 
collagen remodeling and, as consequence, fibroblasts synthesized new collagen molecules 
that were then assembled within the pore spaces and on the surfaces of the gelatin 
microscaffold inducing HD-μTPs assembling. Studies demonstrated that A375 do not 
product collagen (the glue of this system) 60. Reasons to μTP aggregation are to be sought in 
heterotypic cell aggregation capability. Immunofluorescence (figures 2) revealed that A375-
μTP express N-cadherin. N-Cadherin is a cell adhesion protein and member of catenin 
family. Cadherins are a family of glycoproteins involved in the Ca2+-dependent cell-cell 
151 
 
adhesion mechanism. It has been demonstrated that N-Cadherin mediated both homotypic 
than heterotypic aggregation among melanoma cells and have a relevant role in melanoma 
progression 61. Thus cell-scaffold aggregation and consequently tumor μTP formation is due 
to protein adhesion expression. At least MTT assay was used for measuring cell viability and 
activation in the assessment of compatibility between cells and biomaterials. Relationship 
between cell number and μTP aggregation was tested during entire experiment. Figure 3 
shows that the absorbance was directly proportional to the number of cells: A375 cell in 
tumor-μTP are activated and vital and consequently biocompatible to porous scaffold 62. 
These previous analysis have been the starting point for the development of full-thickness 
melanoma model. Indeed biocompatibility of melanoma cells with porous gelatin beads is 
necessary for their future use in a 3D in vitro melanoma model realized by the same scaffold.  
 
4.3 Engineered melanoma model 
4.3.1 Materials and methods 
Fabrication of 3D Human dermis equivalent endogenous Biohybrid  
Spinner cell culture: macroporous gelatine microbeads were obtained by using a double 
emulsion technique. Glyceraldehydes have been used as gelatine crosslinker at 4% w/w of 
the microbeads. The microbeads/fibroblasts cultures were propagated intermittently at 30 
rpm (5 min stirring and 30 min static incubation) for the first 6h post-inoculation for cell 
adhesion, and then continuously agitated at 30 rpm in spinner flasks (100 ml, Bellco). The 
spinner cultures were incubated at 37 °C in 5% CO2. Tissue equivalent assembly: tissue 
precursors obtained by previous step have been injected in maturation chamber to allow their 
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molding in disc-shaped construct (1 mm in thickness, 5 mm in diameter). After 4 weeks of 
culture, under dynamic conditions, the biohybrid obtained has been removed from the 
maturation chamber and seeded with keratinocytes in order to obtain the epithelial layer (for 
details look chapter 2). 
 
Keratinocyte and fibroblast extraction  
Human keratinocytes and fibroblasts were isolated from human foreskins after routine with 
the informed consent of the patient. 
Day 1: separation of dermis from epidermis. Skin sample derived from reduction surgery with 
the informed consent of the patient. Take some ml of the transport solution as sterility control 
and incubate it in a culture flask over night at 37° C. Rinse the biopsy 3 times with PBS, 
remove the PBS but leave a little bit to avoid the biopsy to run dry. Remove hairs from the top 
and all fat and tissue remnants from the bottom side (the better you remove the fat/tissue 
remnants from the bottom side the easier the separation of dermis from epidermis will be the 
next day).Rinse with PBS again, till the PBS stays clear (about 3 times). Determine the size of 
the "purified" skin (important for the amount of enzymes dispase needed; do not determine 
the size before having removed all the fat because the skin will enlarge after the tissue 
remnants are removed). Cut skin into strips of about 3 mm width. Transfer strips into new 
small petri dish, wash with PBS (important: do not use PBS with calcium and magnesium at 
this step). Incubate skin strips with Dispase solution (2 U/mL; about 5-10 ml for 6 cm² of 
skin) that all strips are covered with it and incubate over night for 16 h. 
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Day 2: fibroblast and keratinocyte extraction. Check after 16 h if epidermis has removed from 
dermis (you can see this at the edge where epidermis is partly detached from dermis). Once 
digestion completed, skin strips was transferred to PBS. Separate epidermis from dermis with 
tweezers and storing temporarily dermal tissue at 4° C in cold PBS. 
For keratinocytes extraction wash epidermal parts with PBS. Cut epidermis into small pieces 
(they should be about 4 mm). Transfer pieces into 5 mL of pre-heated Trypsin/EDTA at 
0,05%, wash petri dish with another 5 mL Trypsin/EDTA and transfer it to the tube. Incubate 
Trypsin/EDTA (with cut epidermal pieces) for 5 min at 37° C water bath, vortex shortly every 
1-2 min (important: the water bath temperature has to be 37° C, therefore do not place large 
cold flasks into it as this would reduce the temperature). Stop enzyme reaction by using FBS. 
Resuspend solution for 5 min (plastic single-use pipette) to separate cell clumps Strain 
solution by transferring it to new tube through cell strainer. Use the same pipette with 
prepared 10 mL PBS solution to wash the tube, the single-use pipette and finally transfer 
solution through cell strainer, too. Centrifuge: 5 min 1200 rpm. Resuspend cells in culture 
media and count cells. Seed cells into flasks: 8*10³ cells per cm². Important: full medium 
change after 4 h. (prepuce) or 24 h (adult skin).  After 3 days 2nd medium change (cells 
should feature characteristic morphology now). Let cells culture up to 80% confluency before 
freezing (not more as keratinocytes will start to differentiate). Precaution to take during cell 
extraction: age of donor, gender, amount of cells extracted. Keratinocytes were grown in 
KGM™-2 culture media. The growth medium contains the base medium, separate vial of 
calcium chloride and other supplement mix that are: BPE (bovine pitutary extract), hEGF, 
insulin (recombinant human), hydrocortisone, GA-1000 (gentamicin, amphotericin-B), 
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epinephrine and transferrin. The formulation is optimised for initial seeding of 5000 cells / 
cm² up to sub-confluence.  
For fibroblast extraction dermal tissue scraped eight times on the both surfaces of dermal 
piece in PBS solution to remove endothelial cells. Take the dermal pieces, cut them in small 
pieces and put in 30 ml collagenase A solution (ROCHE) at concentration of 2mg/ml for 40 
minutes at 37° C. After stop the collagenase solution with FBS and centrifuge 5 min 1200 
rpm and resuspend the piece in a little volume of EMEM. Eagle’s BSS Minimum Essential 
Medium containing 20% fetal bovine serum, 100 mg/mL L-glutamine, 100 U/mL 
penicillin/streptomycin, and 0,1 mM Non Essential Amino Acids). In this in this way occurs 
the migration of fibroblasts on the surface of the petri. 
 
Cell culture 
Fibroblasts were grown in enriched Eagle’s BSS Minimum Essential Medium (EMEM) until 
full-confluence. Keratinocytes were grown KGM™-2 culture media (PromoCeLL). Melanoma 
cell lines were purchased from ATCC. The A375 (ATCC® CRL-1619™)) are primary 
melanoma and derived from skin. Melanoma cells were grown in the same medium as 
fibroblast supplemented with 10% of fetal bovine serum until a semi-confluence. One day 
before seeding, melanoma cells were grown in the same medium as keratinocytes. All cells 
were grown at 37° C in 5% CO2 atmosphere. 
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In Vitro Reconstruction of Human 3D Skin and Melanoma  
Dermal reconstruction was realized as previously described. For epidermal realization, the 
mature dermal reconstructs were extracted from maturation chamber, rinsed and left in petri 
dish for 24 h before the use.  
For healthy epidermal reconstruction, dilute human fibronectin (Sigma Aldrich) in sterile 
balanced salt solution e concentration of 50 µg/ml than coat the dermis equivalent surface 
with a minimal volume (about 10 µl for single well). Allow to air dry for at least 45 minutes at 
room temperature. Wash the keratinocyte 3 or 4 times with PBS/EDTA 0.01 M leaving in 
contact for a few second and after. Keratinocyte colonies were detached by using 
trypsin/EDTA for 5 min at 37° C. Gently resuspend cells in culture media, count cells and 
add the appropriate number of cells to a 15-mL tube so that there will be enough cells 
(400,000 cells/insert) to seed onto the desired number of inserts. Centrifuge at 1200 rpm for 
5 min. At this time, cells can be seeded directly onto the dermis equivalent. Resuspend the 
keratinocytes pellet in a small volume needed for plating onto the matrix. It is important to 
resuspend cells in a small volume as 140000 cells will be seeded onto the small surface area 
of the connective tissue (5 mm diameter). This is performed by using a sterile, plastic 200 µL 
pipet to add 50 µL keratinocytes media to the 15 mL tube per 140000 keratinocytes present. 
Gently dislodge the cell pellet and transfer it to a 1.5 mL sterile Eppendorf tube with a 1 mL 
pipet. Gently resuspend the cell pellet in the eppendorf tube with a 200 µL pipet until it is 
cloudy and well suspended and transfer 10 µL of the cell suspension to the middle of tissue. 
Do not touch for 10 min to allow the cells attachment. Incubate at 37° C for 2,5/3 h by 
adding only a drop of culture media each 10 minutes to allow the keratinocytes to fully 
adhere. At this point, in reference to the procedure used, the operator must continue to use 
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the culture media related. Cultures are fed every 2 d in submerged condition for one week. 
Then, cultures are raised to the air/liquid interface by adding only 1 ml to the bottom of the 
well so that the bottom of the insert just contacts the interface with the media for two weeks. 
Additional feedings with KGM-2 culture media without EGF and BPE but with CaCl2 
concentration of 1.88 mM: media are performed for 6 day. 
For incorporation of melanomas, cells were seeded together with keratinocytes onto dermal 
reconstructs at two different concentrations: 1:5 and 1:10 ratio of melanoma cells to 
keratinocytes. A375 (1619) centrifuge at 900 rpm for 4 min. Culture conditions were the same 
as for reconstructs containing keratinocytes alone.. All experiments were performed in 
triplicate. Tumor growth was monitored for 3 weeks evaluating reconstructed skin at: 1 week 
sub-merged, 1 week air-liquid interface, 2 weeks air-liquid interface. 
 
Histological and immunohistochemical analysis of composites  
Tumor growth was monitored for 3 weeks. Morphological analyzes were performed on 
histological section at 6 days of submerged conditions, and at 6 and 12 days after air-liquid 
interface transfer. For further visualization of epithelial structures, tissues were rinse gently in 
PBS, detached from metallic grid by using a thin palette and fixed with 10% neutral-buffered 
formalin fixative for 2–4 h. Healthy and tumor tissues were subsequently stained with H&E 
and cleared in xylene. Whole mounts were mounted with Permount and photographed under 
20× and 40× magnifications. Immunofluorescences were performed on paraffin-embedded 
tissue sections with sodium antigen retrieval, followed by detection with secondary antibodies 
(anti-mouse 488 or anti-rabbit 546; Abcam). Paraffin sections were stained with primary 
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antibody for E-cadherin (1:100, monoclonal, Abcam), K14 (1:1000, polyclonal, Covance), K10 
(1:500, polyclonal, Covance), P63 (1:50, monoclonal, Abcam) and filaggrin (1:200, polyclonal, 
Sigma) after citrate antigen retrieval, to detect epithelial markers. Paraffin sections were 
stained with primary antibody for S-100 (1:100, Abcam) and CD146 (1:100, Abcam) after 
citrate antigen retrieval, to detect melanoma markers. The secondary antibodies used were: 
Alexa fluor 647 goat anti-mouse (Life Techologies, Milano, Italy) and Alexa fluor 546 anti-
Rabbit Anti-Sheep IgG H&L (Abcam). SYTOX® Green (INVITROGEN) for the detection of cell 
nuclei was used. Immunohistochemistry was performed on paraffin-embedded tissue 
sections with sodium antigen retrieval, followed by detection with biotinylated secondary 
antibodies and visualization with DAB substrate (Vector Laboratories). Antibody used on 
paraffin-embedded healthy and tumor tissues sections was N-cadherin (1:100; Abcam). 
Samples were investigated by using confocal microscopy (TCS SP5 II Leica, Milano, Italy). 
A375-µTP and human skin were used as positive controls. 
 
4.3.2 Results and discussions 
We previously reported on the importance of cell-ECM (native BM) and cell–cell (interactions 
between fibroblasts, keratinocytes, melanocytes and melanoma cells) communication in a 3D 
reconstructed skin model, and we showed how disruptions in these forms of communication 
can alter cell biology within this model 7,17. In this study we further investigated the role of skin 
cells and BM components on melanoma biology and invasive ability in reconstructed human 
skin. In this perspective, we first fabricated a human skin reconstructs resembled the 
architecture of skin in situ. The dermal equivalent contained endogenous extracellular matrix 
(composed by mostly collagen but also fibronectin, hyaluronic acid and neutral mucin as 
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described in chapter 3) with interspersed fibroblasts. To fabricate an engineered skin model, 
single-cell suspensions of normal human keratinocytes were seeded onto endogenous 
dermis. In order to fabricate an engineered melanoma model, single-cell suspensions of 
normal human keratinocytes and A375 human melanoma cells derived from RGP were 
seeded. Two different cellular ratios of keratinocytes and A375s were evaluated: 1:5 and 1:10. 
The first experimental set-up with higher tumor density (1:5) presented an epithelial cells 
behaviour that was incapability to generate an epidermis. Figure 1 shows how epithelium was 
not yet formed after 2 weeks of air-liquid interface of culture. We supposed that number of 
melanoma cells was too high to obtain a correctly structured epithelium because of the higher 
replication rate and aggressiveness of A375s respect to the ones of keratinocytes.  
 
Fig .1: HE stain and Immunofluorescence of human skin equivalent in engineered melanoma model at (a) 1 week air-liquid 
interface culture (b,) 2 weeks air-liquid interface culture. 1° condition of experimental set-up: ratio Ker: A375 = 5:1. Paraffin 
section were immunostained for S-100 and Sytox Green as nuclear stain. Scale bar, 50 and 100 µm. 
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Subsequently, single-cell suspensions of normal human keratinocytes and A375 human 
melanoma cells were seeded at the ratio of 1:10 onto endogenous dermis. According to 
ATCC, A375-1619 cell line was derived from human melanoma skin with an epithelial 
morphology. The resultant tissues were allowed to grow and differentiate in serum-free 
medium to form 3D-highly differentiated, full-thickness, skin-like tissues. Reconstituted 
human epidermis was studied at 6th days of submerged conditions and at 6th and 12th days 
starting from the air–liquid interface transfer. Figure 2 shows the appearance and histology of 
composites containing only foreskin-derived keratinocytes and co-culture both keratinocytes 
than melanoma-derived A375. HE stain reveals that during submersion conditions in both 
healthy and tumor conditions, keratinocytes are not able to synthesize some keratin 
polypeptides. Thus, their differentiation results uncompleted, because of the culture 
microenvironment used, that provides environmental conditions dramatically different from 
those occurring in vivo (Fig. 2a and 2d). Conversely, morphology analysis of healthy epidermis 
related to foreskin-derived keratinocytes showed a structured multilayered epithelium at day 6 
(Fig. 2b), evolving at day 12 or air-liquid interface (Fig. 2c) to an organize epithelium 
composed of basal layer, spinosum, granulosum and corneum stratum, similar to that of a 
human skin. Figure 2c shows various layers of progressively flattening keratinocytes with less 
prominent nuclei and constituted by a high keratin content stratum spinosum. In contrast, 
analysis of engineered tumor epidermis obtained from foreskin-derived keratinocytes and 
melanoma-derived A375 revealed unstructured tissue (Fig. 2e), followed by an evolution to a 
flat and degenerative tissue at day 12 (Fig. 2f). The figure shows formation of a barely 
stratified epithelium, displaying a less pronounced red fuchsia color than the one related to 
the healthy tissue at 12 days after air-liquid interface (Fig. 2c and 2f). Morphological analysis 
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also reveals a clusters organization of A375 that does not permit a good epidermal fabrication; 
RGP melanoma cells formed nests within the epidermis and band-like tumor cell aggregates. 
When melanoma cells were incorporated into skin reconstructs, they displayed rapid 
proliferation and aggressive invasive growth deep into full epithelium. We speculated that the 
majority of A375 cells could be located on the surface of the epithelial layer or between basal 
epidermal layer and basement membrane after the end of the two weeks of air-liquid 
interface transfer. RGP primary melanoma cells in these layers could be disposed as 
individual cells and as small nests at the epidermal-dermal junction. Moreover, morphological 
analysis detected a low production of cutaneous appendage with a 3:1 ratio of healthy tissue 
to melanoma tissue. These data and the lack of competence for invasive growth into the 
dermis were confirmed by immunohistochemical analysis.  
 
Fig .2: HE stain of human skin equivalent in engineered healthy model at (a) 1 week submerged culture, (b) 1 week air-liquid 
interface culture, (c) 2 weeks air-liquid interface culture; HE stain of human skin equivalent in engineered melanoma model 
at (d) 1 week submerged culture, (e) 1 week air-liquid interface culture, (f)2 weeks air-liquid interface culture. Scale bar, 100 
µm. 
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To understand how the collectively migrating cells form a multilayered epithelium, we 
analyzed keratinocyte differentiation in both healthy and melanoma engineered tissues in 
submerged conditions and at 6 and 12 days after air-liquid interface transfer. Based on 
immunological staining with antibodies for human keratin 14 (k14), keratin 10 (k10) and 
filaggrin, the state of differentiation of the healthy epidermal layer differed to that visible in 
melanoma construct. K14, typically detected at the stratum basale in human skin, was 
present in the spinous layer only in submerged culture conditions in both healthy engineered 
and melanoma engineered skins, as reported in Fig. 3a and Fig. 3d, respectively. Progressive 
time K14 was present in the well-polarized stratum basale in engineered healthy model, as 
well as in normal epidermal differentiation (Fig. 3b, 3c). Conversely, increased levels were 
observed in melanoma model: after 2 weeks of culture at the air-liquid interface K14 was 
expressed in the upper layers too (Fig. 3e, 3f). 
 
Fig .3: Immunofluorescence of human skin equivalent in engineered healthy model at (a) 1 week submerged culture, (b) 1 
week air-liquid interface culture, (c) 2 weeks air-liquid interface culture; Immunofluorescence of human skin equivalent in 
engineered melanoma model at (d) 1 week submerged culture, (e) 1 week air-liquid interface culture, (f)2 weeks air-liquid 
interface culture. Paraffin sections were immunostained for K14 and Sytox Green as nuclear stain. Scale bar, 50µm. 
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K10 levels also exhibited significant differences between the two models (Figure 4) at the 6th, 
10th and 15th day of culture. After 1 week of growth in submerged conditions, keratinocytes 
showed a really low expression of K10 toward the tip of the epidermis in both models (Fig. 4a, 
4d). At the later time (12th and 18th days), the expression of differentiation marker 
progressively increased (Fig. 4b, 4e). After 2 weeks of culture at the air-liquid interface, K10 
was expressed in all suprabasal epidermal layers of healthy epidermal reconstructed skin (Fig. 
4c) indicating a progressive differentiation process. At this time, organotypic model seeded 
with A375s cocultured with keratinocytes expressed lower levels of K10 (Fig. 4f), reflecting a 
less differentiated status. In our model, A375 melanoma cells seem to prevent epithelial 
differentiation.  
 
Fig .4: Immunofluorescence of human skin equivalent in engineered healthy model at (a) 1 week submerged culture, (b) 1 
week air-liquid interface culture, (c) 2 weeks air-liquid interface culture; Immunofluorescence of human skin equivalent in 
engineered melanoma model at (d) 1 week submerged culture, (e) 1 week air-liquid interface culture, (f)2 weeks air-liquid 
interface culture. Paraffin sections were immunostained for K10 and Sytox Green as nuclear stain. Scale bar, 50µm. 
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These data were confirmed by filaggrin detection: with progressive time, the expression of 
K14 and K10 are down regulated in the upper layers, while structural proteins, such as 
filaggrin, are upregulated in engineered in our healthy model as well as in vivo. Indeed, 
between days 6 and 12 after air-liquid interface transfer, filaggrin expression increased in 
foreskin-keratinocytes-derived model, indicating a progressive differentiation process (Fig. 5b, 
5c). Thus, filaggrin expression, whose signal was detectable only in the upper layers of 
epidermis, displayed a correct and a well-differentiated epidermis. Conversely, no filaggrin 
expression was revealed by the same analysis in the melanoma model (Fig. 5d, 5e, 5f). 
 
Fig .5: Immunofluorescence of human skin equivalent in engineered healthy model at (a) 1 week submerged culture, (b) 1 
week air-liquid interface culture, (c) 2 weeks air-liquid interface culture; Immunofluorescence of human skin equivalent in 
engineered melanoma model at (d) 1 week submerged culture, (e) 1 week air-liquid interface culture, (f)2 weeks air-liquid 
interface culture. Paraffin sections were immunostained for Filaggrin and Sytox Green as nuclear stain. Scale bar, 50µm. 
 
 
To investigate the reason of lack epidermis differentiation in melanoma model, we examined 
the epithelial cell capability to express p63. Analysis at submerged conditions and 1 and 2 
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weeks after air-liquid interface transfer, relieve that p63 is regular expressed in healthy model 
(Fig. 6a, 6b, 6c) and is completely absent in melanoma model (Fig. 6d, 6e, 6f). Figure 6c 
shows that P63/K10 signals exhibits a differentiation patterns in healthy model equal to 
normal human epidermis (K10 that identifies the suprabasal cells, is located above the p63 
signal) and also figure 6f shows a total absence of P63 expression in melanoma model. 
Previous studies established that p63 is required in development for proper epidermal 
stratification and differentiation 63. Truong et al. (2016) have been demonstrated that p63-
deficient primary human keratinocytes exhibited hypoproliferation. In details simultaneous p63 
and p53 knockdown rescued the cell proliferation defect of p63 knockdown alone but failed to 
restore differentiation, suggesting that defects in epidermal proliferation and differentiation 
are mediated via p53-dependent and -independent mechanisms, respectively 64. These 
considerations explain the low and absent signals of K10 and filaggrin, respectively, in 
melanoma model. Also, the basal keratin 14, which are expressed throughout the epithelium 
of regenerating tissue, was not altered because of p63 may not directly regulate expression of 
these proteins in this setting 60,64. Together, these results suggest that the lack of epithelial 
differentiation in melanoma model could be attributed to A375 cells capability to inhibit the 
production of P63 in keratinocytes.  
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Fig .6: Immunofluorescence of human skin equivalent in engineered healthy model at (a) 1 week submerged culture, (b) 1 
week air-liquid interface culture, (c) 2 weeks air-liquid interface culture; Immunofluorescence of human skin equivalent in 
engineered melanoma model at (d) 1 week submerged culture, (e) 1 week air-liquid interface culture, (f)2 weeks air-liquid 
interface culture. Paraffin sections were immunostained for P63 (blue) and K10 (red). Scale bar, 50µm. 
 
 
In the last decades the role E-cadherin in epidermal differentiation process has been 
demonstrated. Experimental evidence indicates that epidermal deletion of the cell-cell 
adhesion protein, E-cadherin, results in delayed progression of epidermal differentiation 65. E-
cadherin is necessary for epidermal differentiation, and the loss of this protein mediated 
adhesion shifts the homeostatic balance toward proliferation 66. Thus, further investigations on 
differentiation process were carried out by monitoring cadherins expression in both systems 
(Fig. 7 and Fig. 8). E-cadherin was immunolocalized in basal and suprabasal cells of the 
engineered normal model, showing functional adherens junctions and microfilaments in the 
full length of the engineered tissue (Fig. 7a, 7b, 7c). E-cadherin was strongly expressed in 
basal keratinocytes and specialized epithelial structures. A natural gradient of E-cadherin 
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mediated adhesion exists within the normal engineered epidermis such that increasing 
adhesion correlates with the progression of time and, consequently, differentiation (Fig. 7). 
Therefore, E-cadherin mediated adhesion may function as a microenvironmental cue to 
promote epidermal differentiation. Investigations of E-cadherin expression in melanoma 
model (Fig. 8), reveals that the levels of expression were significantly different among cells of 
the healthy and tumor engineered models at each time of detection (Fig. 8a, 8b, 8c). The 
expression levels resulted significantly lower in tumor engineered model and cells in the upper 
layer of epidermis did not express E-cadherin at 1 and 2 weeks of air-liquid interface (Fig. 8b, 
8c). We already demonstrated that epithelial cells in the melanoma model do not 
differentiated and realize corneum stratum, moreover the analysis revealed the presence of 
nucleic cells in the upper layer of epidermis of engineered melanoma model. In order to 
understand the nature of these cells, N-cadherin expression was investigated and compared 
with E-cadherin expression. IHC of N-cadherin revealed a positive signal in tumor model 
exactly in correspondence of negative E-cadherin-cells (Fig. 8a, 8b, 8c compared with 8d, 8e, 
8f respectively, arrow). N-cadherin was not detected in healthy model at any time (Fig. 7d, 7e, 
7f). The biology of tumour invasion and metastasis is a multistep process, dependent on the 
outcome of a series of interactions between tumour cells and host cells or tissues. These 
phases include growth, angiogenesis, detachment, migration and release, as well as survival 
and migration of the metastasis, followed by invasion and implantation. Invasion itself is a 
complex process involving proteolysis of tissue barriers, as well as alteration in cell/cell and 
cell/matrix interactions. Increasing evidence implicates reduced expression of E-cadherin with 
increased metastatic potential of epithelial cancers. Despite the loss of E-cadherin expression 
by melanoma cells, cells in tumor model express high levels of N-cadherin as well as in vivo 
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happen 29,30,66,67. It have been demonstrated that the switching of cadherin subtypes during 
melanoma development allows melanoma cells to interact directly with other N-cadherin- 
expressing cells, such as fibroblasts, thus affecting tumor-host cell adhesion, tumor cell 
invasion and migration, and gene expression 26. Potential role of N-cadherin in the 
development and progression of melanoma is widely demonstrated. N-Cadherin mediating 
homotypic and heterotypic aggregation improve cells ability to migrate through basement 
membrane 68,69.  
 
Fig .7: Immunofluorescence of human skin equivalent in engineered healthy model at (a) 1 week submerged culture, (b) 1 
week air-liquid interface culture, (c) 2 weeks air-liquid interface culture; paraffin sections were immunostained for E-cadherin 
and Sytox Green as nuclear stain. Immunohistochemistry of human skin equivalent in engineered healthy model at (d) 1 week 
submerged culture, (e) 1 week air-liquid interface culture, (f) 2 weeks air-liquid interface culture; paraffin sections were 
immunostained for N-cadherin. Scale bar, 50µm. 
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Fig .8: Immunofluorescence of human skin equivalent in engineered melanoma model at (a) 1 week submerged culture, (b) 1 
week air-liquid interface culture, (c) 2 weeks air-liquid interface culture; paraffin sections were immunostained for E-cadherin 
and Sytox Green as nuclear stain. Immunohistochemistry of human skin equivalent in engineered melanoma model at (d) 1 
week submerged culture, (e) 1 week air-liquid interface culture, (f) 2 weeks air-liquid interface culture; paraffin sections were 
immunostained for N-cadherin. Scale bar, 50µm. 
 
 
These considerations are a proof that the tumor cells in melanoma model could be acquired a 
radial growth phenotype as well as in vivo. This could be explained the presence of cells with 
an intense dark color in HE stain (Fig. 2e, 2f, arrows) – indicating presence of A375 
melanoma cells – at the epidermal-dermal junction. At this point, we confirmed tumor nature 
of these cells and, consequently, the localization of melanoma cells within the organotypic 
model by immunohistochemical analysis for the expression of the S100 and CD146 proteins. 
The cells presenting clusters organization, isolated from the tumor model, showed a 
significantly high expression of S100 and CD146 (Fig. 9). Conversely, healthy model does not 
express these two markers (data not shows). These results demonstrated clusters 
organization of A375 and formation of nests on top of epidermis. Moreover, Fig. 9b, 9e display 
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a rapid proliferation and aggressive invasive growth deep into full epithelium still after 1 week 
of air-liquid transfer. Data confirmed that at the end of a two weeks culture period, the 
majority of A375 cells are located on the surface of the epithelial layer and between basal 
epidermal layer and basement membrane (Fig. 9c, 9f). A375-RGP primary melanoma cells are 
disposed as a continuous layer of cells and as small nests at the epidermal-dermal junction. 
Detection of S-100 and CD146 also permitted to investigate cutaneous appendage nature. As 
previously mentioned, HE stain revealed the presence of epithelial cyst-like inclusions in their 
dermal portion; in addition, the number of cutaneous appendage decreased in engineered 
tumor model. Indeed, this cyst-forming capability was rarely observed in tissues composed 
both of keratinocytes than A375. We demonstrated that all cysts in dermis compartment are 
healthy and only composed by keratinocytes (Fig. 10, arrows). A375s formed cell nests within 
the epidermal layer but showed no propensity for dermal invasion. In engineered tumor model, 
A375 cells derived from primary tumor sites formed large compact (Fig. 9c, 9f) and small 
aggregates (Fig. 10a, 10c, 10e) over the basal layer of the reconstructed epidermis. However, 
they did not spread into the dermis (Fig. 10b, 10d, 10f). Similar results were already reported 
in literature in the presence of melanoma cells from primary tumor, where intra-epidermally 
growing nodules were bordered by an intact basement membrane but they did not 
disintegrate it 57,70,71.  
 
170 
 
 
Fig .9: Immunofluorescence of human skin equivalent in engineered melanoma model at (a) 1 week submerged culture, (b) 1 
week air-liquid interface culture, (c) 2 weeks air-liquid interface culture; paraffin sections were immunostained for S-100 and 
Sytox Green as nuclear stain. Immunofluorescence of human skin equivalent in engineered melanoma model at (a) 1 week 
submerged culture, (b) 1 week air-liquid interface culture, (c) 2 weeks air-liquid interface culture; paraffin sections were 
immunostained for CD146 and Sytox Green as nuclear stain. Scale bar, 50 µm. 
 
Fig .10: Investigations of cutaneous appendage in melanoma model after 2 weeks of air-liquid interface transfer. Paraffin 
sections were immunostained for S-100 and Sytox Green as nuclear stain in epithelium (a) and in dermis (b). Paraffin 
sections were immunostained for CD146 and Sytox Green as nuclear stain in epithelium (c) and in dermis (d). IHC of Paraffin 
sections for N-cadherin in epithelium (e) and in dermis (f). Scale bar, 50 µm. 
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The ability of melanoma cells from primary tumor to migrate into the epidermal layers leads to 
a radial invasion 57. Over the years, in many in vitro melanoma studies have already been used 
3D engineered models to look at the invasive behaviour of different metastatic human 
melanoma cell lines and different interaction with skin keratinocytes and fibroblasts. 
Commonly, the growth patterns of melanoma cells representing different stages of tumor 
progression was analysed by comparing the phenotypes and the behavior of melanoma cells 
derived from primary and metastatic sites 55–58,72. The results have been demonstrated that 
non-metastatic melanoma cell lines are incapable of dermal invasion 57, whereas metastatic 
cell lines breached the BM and readily invaded the dermis 58 . Moreover, it has been recently 
observed that invasive capacity of melanoma cells is strongly dependent on the presence or 
absence of a BM too. Indeed, under certain circumstances, high metastatic cells also failed to 
invade the dermis when BM structure was confirmed. For examples, in the presence of a BM 
a significantly reduction of A375-SM invasion was observed 55,70,71. Therefore BM results in a 
functional barrier for melanoma invasion for both tumor cell lines. Degradation of the 
basement membrane has also been correlated with the metastatic potential of tumor cells 70. 
As generally reported 71 , tumor cells have been considered to be invasive if they are capable 
of overcoming basement membrane barriers alone. Taking into account the incapability of 
A375s to infiltrate dermis (Fig. 10 arrow), we focused analyses on basement membrane 
detection in the tumor model through immunohistochemical localization of laminin. Laminin is 
a glycoprotein that is present in the basal membrane and is considered as a biochemical 
equivalent of the anchoring filaments fixing basal keratinocytes to the basement membrane 73. 
As a readily detectable basement membrane component, laminin can be used as a marker for 
presence of intact or degraded basement membrane during tumorigenesis 74. Figure 11 
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reveals that the expression was continuous around the basement membrane in healthy model 
(Fig. 11a, 11b, 11c) and discontinuous and frequently frammented in melanoma model (Fig. 
11d, 11e, 11f). Engineered healthy model showed more laminin expression and nothing loss 
of continuity compared to melanoma model, whose higher loss of continuity suggests a 
greater enzymatic degradation of basement membrane components. Comparing cutaneous 
appendage formation with basement membrane localization, we definily demonstrate that 
A375s cysts are localated just over basement membrane, as well as reported by Gibot et al. 
(2013), highlighting formation of small aggregates over the basal layer of the reconstructed 
epidermis, without spreading into the dermis 72. The aggressive nature of this cell line well 
fitted with its in vivo characterisation 75.  
 
 
Fig .11: Immunofluorescence of human skin equivalent in engineered healthy model at 2 weeks air-liquid interface culture at 
low (a) and high (b) magnification. Immunofluorescence of human skin equivalent in engineered melanoma model at 2 weeks 
air-liquid interface culture at low (c) and high (d) magnification. Paraffin sections were immunostained for laminin V and 
DAPI as nuclear stain. Scale bar, 50µm. 
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Finally our data demonstrate that the engineered healthy model derived from foreskin 
keratinocytes showed a structured multilayered epithelium at day 6, evolving at day 12 to an 
organized epithelium similar to that of a human skin. Conversely, the present 3D culture 
model of skin melanoma revealed unstructured and disorganised epidermal tissue, including 
tardive cutaneous appendage formation at day 6, followed by an evolution to a flat and 
degenerative tissue at day 12. Engineered tumor model also exhibited good stability and well 
recapitulated radial growth phase phenotype, exhibiting the biological characteristics of 
proliferation and invasion of RGP (according to ATCC, A375-1619 derived from human 
melanoma epithelium). Melanoma cells not spreaded into the dermis but interfere with 
epidermal differentiation preventing p63 expression and destroying BM. The slightly less 
intense and dispersed basal membrane staining, observed where it is in direct contact with 
A375 cell nodules, could be explained by the loss of contact between the basal membrane 
and the epidermal basal cells that are directly responsible for its generation.  
 
4.4 Conclusions 
We fabricated a 3D human skin equivalent (3D-HSE) model with an endogenous stroma as 
dermis component (see chapter 2) to study an aggressive and rare form of skin cancer: 
melanoma. We underlined the importance of cell-ECM – with native basement membrane 
(BM) – and cell–cell (interactions between fibroblasts, keratinocytes, melanocytes and 
melanoma cells) communication involved in carcinogenesis. The disruptions in these forms of 
communication can alter cell biology of human skin 7,17. Consequently, we investigated the role 
of skin cells and BM components on melanoma biology and invasive ability in reconstructed 
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human skin equivalent. We first made-up and characterized a human skin model that 
resembled the architecture of skin in situ, than we carried out an analogous procedure for the 
equivalent engineered tumor model. On the basis of our results, we can assert that there is 
communication between skin cells and melanoma cells and the outcome is dictated by the 
nature of the melanoma cells. Thus, the bioengineered 3D melanoma skin model may 
become a valuable tool to investigate the underlying mechanics of melanoma infiltration. The 
proposed study does not recapitulate yet melanoma metastasis process as a whole, however, 
the present engineered 3D tissue represents a reliable model for investigating the phenotype 
and behavior of melanoma cells derived from primary sites. Indeed, the 3D melanoma skin 
model is suitable to study the biological properties of radial growth phase invasion. This study 
represents a preliminary model for investigating all aspects of melanoma metastasis and it 
has great potential for improving our understanding of the interactive biology between 
melanoma cells and their immediate surroundings and evaluating melanoma cells influence 
on epidermis structure and differentiation.  
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